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ABSTRACT
Heme is a source of iron for many pathogenic bacteria. Corynebacterium diphtheriae, the
first protein in the system is HtaA, ChtA, and/or ChtC; heme is transferred to HtaB or ChtB. Heme
is then mobilized into the cytosol by the ABC transporter where iron is released by the heme
oxygenase.
Growth and expression temperatures for ChtA were of 37 °C and induction OD600 between
0.6 and 0.9. Final IPTG concentration of 0.3 mM. ChtA extinction coefficient is 1.4 x 105 M-1 cm1

at the Soret. ChtA is less stable than HtaA-CR2 to denaturation in guanidinium hydrochloride.
Dechloromonas aromatica chlorite dismutase (DaCld) detoxifies chlorite to chloride and

dioxygen. Chlorite sources often have nitrite. The goal is to identify the structure of this adduct.
Temperatures of growth and expression, 30 and 20 °C, respectively, an induction OD600 of
0.30, and a final IPTG concentration of 0.1 mM resulted in the desired holo DaCld.
INDEX WORDS: Corynebacterium diphtheriae, Staphylococcus aureus. Streptococcus
pyogenes, Dechloromonas aromatica, Heme, Heme uptake, Heme transfer, Axial ligand, UVvisible absorption spectroscopy, Resonance Raman spectroscopy, Unfolding, and Denaturing
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INTRODUCTION

In the mammalian host, the availability and distribution of iron are highly controlled (14).
Iron is complexed within the porphyrin ring in hemoglobin (Hb) and myoglobin (Mb).
Degradation of heme by heme oxygenases release iron (15). After cell lysis, transferrin, albumin,
lactoferrin, and hemopexin readily bind to the free heme to prevent oxidative damage (16).
Under physiological conditions, approximately 10-9 M of free iron is available (15, 17). A much
higher concentration of iron (10-6 M) is required for optimal bacterial growth. It is, therefore, not
surprising that pathogens continue to develop mechanisms to take up iron from the host. Due to
constant evolving antibiotic resistance, new ways of controlling bacterial infections are urgently
needed. In hopes of developing alternative antibiotic therapeutics, it is useful to study heme
uptake in heme proteins.
Corynebacterium diphtheriae is a Gram-positive bacterium that causes infection in the
upper respiratory tract and skin (18). In acute cases, bacterial growth remains localized at the
infection sites, but diphtheria toxin (DT) is released into the blood, causing severe systematic
pathology. Early studies indicated that the tox gene in C7 strains was repressed in a high-iron
environment (16, 19, 20). When bound to iron, DtxR-Fe binds to the operator of the tox gene and
acts as a transcriptional repressor, which inhibits DT synthesis (21-23). While vaccines exist
(e.g., DTPcv-3), as of 2018, 24% of the world population was either under- or un-immunized
(24). Consequently, diphtheria infections still occur in parts of the world with low vaccine
coverage (25, 26).
In the 1950s, diphtheria was controlled both in the Russian Federation and the United
States (27). A diphtheria re-emergence of the gravis biotype started in the Russian Federation in
the early 90s and lasted approximately two years. Studying this strain of C. diphtheriae, the
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laboratory of Dr. Michael Schmitt identified hmuTUV genes involved in the utilization of heme
that are homologous to the genes involved in the Gram-negative heme uptake systems (20).
HmuT is a lipoprotein that anchors to the cytoplasmic membrane and serves as a heme receptor
(8, 28). The protein transfers its heme to the ABC transporter (HmuU and HmuV), in which
heme is mobilized into the cytosol, where iron is released by heme oxygenase (HmuO). The
hmuTUV genes are associated with the htaABC gene cluster (29). Additional chtA, chtB, and
chtC genes have also been identified (8). Schmitt and colleagues suggested that different isolates
of C. diphtheriae may utilize different heme uptake systems.
A second project consists of heme nitration in Dechloromonas aromatica chlorite
dismutase (DaCld). Clds are heme proteins that efficiently decompose chlorite (ClO-) into
chloride (Cl-) and oxygen (O2) (30). ClO- contamination is a rising environmental concern;
consequently, Clds may come to play an industrial role in catalyzing the degradation of ClO-.
Nitrite (NO2-) can often be present with ClO-; therefore, it is essential to understand the products
from the reaction of NO2- with Clds. Our goal is to identify the products of the reaction of nitrite
with DaCld.
This thesis consists of four chapters. Chapter 1 is the background of the heme uptake in
pathogenic bacteria, including systems based on HtaA and NEAT domains. Chapter 2 is the
manuscript entitled “Characterization of homologous heme uptake proteins HtaB, ChtB, and
ChtA from Corynebacterium. diphtheriae," which is to be submitted to a peer-reviewed journal.
Chapter 3 details additional ChtA and experiments that do not appear in the manuscript. Chapter
4 describes our studies to date on the nitration of hemin in chlorite dismutase.
Herein, the Gram-positive heme uptake systems investigated are based on two traditional
conserved protein domain families: HtaA and NEAT.
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The HtaA domain can be compared with the well-studied NEAT domains (31). Figure
1.1 shows the gram-positive bacteria divided into two groups, Firmicutes (low GC) and
Actinobacteria (high GC). Clinically relevant Firmicutes include Bacillus, Clostridium, Listeria,
Staphylococcus, and Streptococcus, all of which use the NEAT domain and almost none of
which have sequences homologous to HtaA (15). Examples of clinically relevant Actinobacteria
include Actinomycetes, Corynebacterium, Propionibacterium, Rothium, and Streptomyces. All of
these have sequences homologous to HtaA, but almost none have sequences homologous to
NEAT. Thus, there seems to be a divide in the strategies used for the main pathway of heme
uptake in clinically relevant examples of these two phyla of bacteria, with Firmicutes using
NEAT and Actinobacteria using HtaA.
1.1

Binding domains in heme-uptake proteins
1.1.1

NEAT

NEAT domains are conserved units that bind either or both heme and heme proteins (3133). The domain is composed of ~125 amino acids and tethered to the extracellular side of the
bacterial cell membrane. The conserved region of the NEAT domain is mostly 𝛽-strands. Most
NEAT domains have a YXXXY heme-binding motif, in which one tyrosine serves as the axial
ligand, and the second is the hydrogen-bonding partner of the first. On the opposite side of the
heme, an SXXXXY/F sequence is commonly found in the 310-helix. In this motif, the serine
forms a hydrogen bond with the propionate and the tyrosine stacks with heme. Figure 1.2 shows
the alignment of conserved residues thought to be involved in the heme uptake process.
As of this writing, there are 87 structures, 93 architectures, 208 species, and 769
sequences known for NEAT domains (InterPro, IPR006635) (15, 31). It is common to have more
than one NEAT domain in a given protein. Because the Isd system of Staphylococcus aureus has
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been studied in the most detail, this review will concentrate on this system; the Shr system from
Streptococcus pyogenes is also discussed at the end of this section.
1.1.2

HtaA

HtaA domains are conserved units of heme proteins involved in binding the heme,
extracting the heme, and transferring it into the cell (28). As of this writing, there are 49
architectures, 365 species, 1038 sequences, and 9 structures known for HtaA domains (InterPro,
IPR007331) (4). It is common to have more than one domain in a given protein. Most HtaA
domains coordinate heme iron via tyrosine.
Figure 1.3 shows most HtaA domains have two conserved tyrosines, one (Y1) 15
residues from the beginning of the N-terminus, and the second (Y2) about 133 residues from the
first (pfam04213). Y1 is the axial ligand and Y2 forms a hydrogen bond with one of the heme
propionates (4). There is also a histidine (H) about 53 residues from the first tyrosine, which has
also been considered a hydrogen-bond partner to the axial ligand. The role of the highly
conserved tryptophan towards the start of the sequence is not yet understood (8, 20, 28, 34-36).
1.2

Heme-uptake in Staphylococcus aureus
The S. aureus Isd system exploits 12 proteins to bind the heme, extract the heme, transfer

it into the cell, and oxidize the tetrapyrrole ring to release the iron (37). Four of the proteins are
surface-anchored (Isd-ABCH). Isd-DEF are heme transporters; IsdI and IsdG are heme
monooxygenases (Figure 1.4) (5). S. aureus can acquire iron from hemoglobin, the hemoglobinhaptoglobin (Hb-Hp) complex, and myoglobin (Mb).
The first step of the S. aureus heme acquisition process is initiated via IsdB or IsdH on
the bacterial cell surface (38). The intact heme is sequentially transferred to IsdB, followed by
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IsdC, and eventually passed to IsdE. A specific order of heme transfer occurs between IsdA,
IsdC, and IsdE: IsdA makes the transfer to IsdC, followed by a transfer to IsdE which eventually
transfers the heme to the cytosol through an ABC transporter.
Herein, we focus on the proteins in the pathway which bind hemin via NEAT domains
(IsdH, IsdB, IsdA, and IsdC) and also discuss IsdE.
1.2.1

IsdH

The first NEAT domain of IsdH in S. aureus (IsdHN1) does not bind heme, but rather
hemoglobin (38-40). An x-ray structure shows the details of the interface (PDB 3SZK) (41).
Pilpa et al. replaced each of the residues in the binding sequence YYHFF with alanine and found
that the Hb binding (Kd of 17 nM) was reduced by 153-, 134-, 72-, 42-, and 14-fold, respectively
(38). IsdHN1 also binds Hp with a Kd of 35 nM. Mutation of any of the YYHFF signature
residues to alanine significantly reduces or prevents Hp binding.
The second and third NEAT domains are linked together via a ~70 amino acid 𝛼-helical
domain (IsdHN2N3) (39). These domains work in concert to bind Hb and take up the heme. A
crystal structure of intact Hb with IsdHN2N3 shows the IsdHN2 domains each binding one of the
Hb chains, while the IsdHN3 are each positioned near the corresponding heme (PDB 4IJ2; Figure
1.5) (10). The second NEAT domain of IsdH (IsdHN2) binds Hb, Hp (38, 39), and the Hb-Hp
complex (38, 42). No heme binding was observed for IsdHN2 (39). The third (IsdHN3) domain
binds heme (Ka of 3.2 × 10! 𝑀"# ) but not Hb (39, 43).
1.2.2

IsdB

The first NEAT domain of IsdB in S. aureus (IsdBN1) does not bind heme (31, 38).
Consistent with this, this domain does not contain the established heme-binding (YXXXY) motif
nor an SXXXXY/F sequence in the 310-helix; instead, these motifs are replaced by FYHYA and
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EEKYD, respectively. The domain binds both 𝛼-Hb and 𝛽-Hb subunits (44). Mutating F164 and
Y167 to alanine resulted in a reduced Hb binding by ~1.8-fold compared to the wild type.
The second domain of IsdB (IsdBN2) has a heme-binding conserved motif (YDGQY) and
a 310-helix sequence (SMMDTF) on the opposite side (15, 31, 38). The crystal structure of hemebound IsdBN2 shows that the M362 and Y440 axial ligands coordinate heme iron from opposite
directions (45). Y444 forms a hydrogen bond with Y440, in addition to stacking with the heme
porphyrin ring, while S361 forms a hydrogen bond with one of the heme propionates. Mutation
of these tyrosine and serine residues to alanine, and methionine to leucine, decrease heme
binding by ~1.8-fold.
IsdBN2 binds both Hb and the Hb-Hp complex (44). For Hb, IsdBN2 prefers binding the 𝛼Hb subunit, interacting with histidine of the subunit. No interaction with the 𝛽-Hb subunit was
observed.
The first and the second (IsdBN1N2) domains are linked together via a ~66 residue 𝛼helical domain (46). In the crystal structure of intact Hb with four IsdBN1N2, the IsdBN1 domain is
observed to bind solely to the 𝛽-Hb subunits (PDB 2DN1) (44). Double mutation of the FYHYA
motif in the first domain (F164D, Y167D) resulted in a 90% reduction in heme transfer
compared to wild type.
1.2.3

IsdA

IsdA has a single NEAT domain (IsdAN) with a heme-binding conserved motif
(YDGQY) and a 310-helix sequence (SHMDDY) on the opposite side (15, 33). As illustrated in
Figure 1.6, the crystal structure of heme-bound IsdA (PDB 2ITF) (47) shows that the Y166 and
H83 axial ligands coordinate heme iron from opposite directions (9). Ser82 forms a hydrogen
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bond with H87 and one of the heme propionates. The heme-iron interacts with Y166 and Y170;
the latter also stacks with the heme porphyrin ring.
1.2.4

IsdC

IsdC has a single NEAT domain (IsdCN) consisting of ~125 amino acids (48). This
domain has an established heme-binding (YXXXY) motif and a 310-helix sequence SXXXXY
(31). The 310-helix is said to undergo a transition from a flexible to rigid conformation as the
heme is captured (48). The crystal structure of the heme-bound IsdC (PDB 2O6P) shows that the
Y132 and Ile48 axial ligands coordinate heme iron from opposite directions (9). Ser47 forms a
hydrogen bond with Ile48 and one of the heme propionates. Y132 is the axial ligand for the heme
(49). The domain binds heme with a Kd of 0.34 ± 0.12 𝜇M. The domain receives heme either
directly from IsdH and IsdB or through IsdA and is in turn delivered to IsdE (50, 51). Paoli and
colleagues have suggested IsdC is the central conduit through which the heme is passed across
the membrane (49).
1.2.5

IsdE

IsdE has two non-NEAT substrate-binding domains connected via a single 𝛼-helix (52,
53). The protein coordinates the heme iron via M78 and H229. IsdE is reported to bind hemin
with a Kd too tight to measure (54); double mutations of the axial ligands to alanine decreased the
ability of the protein to bind heme (Kd of 9.1 × 10-6 M). IsdE does not transfer heme to IsdA, nor
does it accept heme from IsdA. IsdC selectively transfers heme to IsdE (55). The difference in
heme dissociation constants partly steers the specific sequential transfer of Isd proteins: IsdA >
IsdC >>> IsdE.
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1.3

Heme-uptake in Streptococcus pyogenes: Shr
The Shr protein of the S. pyogenes heme acquisition system has two NEAT domains;

ShrN1 and ShrN2 (56). The protein binds the heme and transfers it to Shp; the HtsABC transporter
relays heme across the cell envelope (57). Figure 1.7 provides a schematic of the heme uptake
pathway (12).
The first NEAT domain (ShrN1) has an SXXXA sequence in the 310-helix and a DXXXY
heme-binding motif downstream of the signaling peptide (15, 58). These motifs differ from the
canonical 310-helix of SXXXXY/F and YXXXY sequences in the domain architecture with heme
acquisition proteins. The domain takes up heme from Hb (58). A recent X-ray structure shows
that the domain binds Hb (59).
The second NEAT (ShrN2) domain has an SXXXA sequence in the 310-helix and a
VXXXK heme-binding motif in the N- and C-terminal regions, respectively (60). This NEAT
domain binds heme but not Hb. Eichenbaum and colleagues have suggested that the main
functionality for ShrN1 is to deliver heme to ShrN2 and that ShrN2 may serve as a heme storage
domain, which can transfer heme back to ShrN1 for movement along the pathway when the heme
level drops (61).
The second and the third (ShrN1N2) domains are linked via a central leucine rich-repeat
(LRR) region (62). ELISA studies by Ouattara et al. indicate that Shr binds only the holo form of
hemoglobin (61).
1.4

Heme uptake in C. diphtheriae
The C. diphtheriae heme uptake system exploits eight proteins to bind and transfer heme

into the cell (Table 1.1). The first protein in the system is HtaA, followed by HtaB and HmuT.
The proteins ChtA/ChtC (homologous to HtaA) and ChtB (homologous to HtaB) are also present
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in the bacterium (1, 28, 36). All of these proteins can acquire iron by utilization of hemoglobin
(Hb), myoglobin (Mb), human serum albumin (HSA), and hemopexin (Hpx) heme sources.
Table 1.2 shows the effect of mutations on the ability of the bacterium to utilize heme iron from
some of these sources. However, only HtaA and either ChtA or ChtC can bind and extract heme
from hemoglobin-haptoglobin (Hb-Hp) complex (36).
For the HtaA pathway in C. diphtheriae, HtaA transfers heme to HtaB (1, 8). It is known
that HtaB and ChtB can substitute for one another (8); ChtB and HtaB can also transfer heme to
one another (Chapter 2). Uluisik et al. used biophysical studies (1) to support earlier the
conclusion from biochemical studies (8, 36) that tyrosine is the axial ligand. Replacing Y1, Y2,
and H of the second HtaA domain (HtaA-CR2) to alanine resulted in reduced heme binding in
the order Y1A > HA > > Y2A > wild type (1). The conserved domains of HtaB, ChtB, ChtA, and
ChtC only share ~25% identity with the HtaA-CR2.
ChtA has a single conserved domain (ChtA-CR) (Allen et al., 2013). In this domain, there
are three conserved tyrosines, two as described in the pfam04213 above; the third (Y3) is in the
place of the conserved histidine in the HtaA sequence. ChtA-CR binds heme from both Hb and
Hb-Hp complex (36). Mutants Y1A and Y2A resulted in two-fold decreases in heme binding.
The domain binds Hb with a Kd of 0.24 μM; the full protein binds Hb with a slightly lower Kd of
0.41 μM (8). ChtA-CR also showed the ability to bind the Hb-Hp complex (EC50 of 890 nM)
~two-fold more strongly than full-length ChtA (EC50 of > 2 µM) (36). Replacing the third
tyrosine with a histidine reduced the ability of C. diphtheriae to utilize Hb as a sole iron source.
Schmitt has taken these data to indicate that there is a distinction in heme-binding sequence
selectivity between ChtA and HtaA (36). Strains with chtA gene deletions were still capable of
utilizing both Hb and Hb-Hp iron sources, similar to wild type. However, a double gene deletion
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(chtA and chtC) affected the bacterial growth. Therefore, ChtA and ChtC may play a similar
function in the heme uptake system. The growth was fully abolished for the triple gene deletion
(chtC, chtA, and htaA) mutants. ChtA and ChtC are of interest because heme in the Hb-Hp
complex can be extracted only when both HtaA and ChtA/C are available (36).
1.5

Protein conformation via charge distribution envelope
Stillman and colleagues have argued that the charge distribution envelope in the mass

spectrum of a protein can be used to assess conformation (54). The S. aureus M78A and H229A
apo-IsdE double mutant had a charge distribution identical to that of wild type. Stillman has
taken these data to indicate that mutation of the axial ligands did not affect the overall structure
of the protein.
1.6

The role of heme pocket residues in controlling heme binding
Collision-induced mass spectrometry has been used to analyze contributions of various

residues that contribute to the binding of the heme in the pocket (63). Draganova et al. replaced
H136, R237, Y272, and M292 of C. diphtheriae HmuT with alanine and found out that heme
was lost as the voltage was increased in the order M292 >> Y272A >>> H136A R237A >> wild
type. Dixon and colleagues argue that in addition to the canonical tyrosine ligand, other
conserved residues contribute to maintaining heme pocket integrity.
1.7

Detecting heme transfer via electron spray ionization mass spectroscopy
Mass spectrometry has been used to study heme transfer between proteins (54, 64). IsdC

transfers heme to IsdE, as indicated by the peak presence of apo-IsdC and holo-IsdE after
incubation of holo-IsdC with apo-IsdE. The 100% heme transfer between the two proteins is an
indication that IsdC and IsdE may be specific natural partners. IsdE does not transfer heme to
IsdC, as indicated by the presence of neither holo-IsdE nor apo-IsdE after holo-IsdC was
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incubated with apo-IsdE for one h.
1.8

Heme transfer between specific partners
As described above, electron spray ionization has been used to show that heme transfer

occurs between specific partners in the S. aureus Isd pathway.
Stillman and colleagues have proposed that mass spectrometry data can be used to
establish heme transfer between specific partners (54). No heme gain or loss was observed
between holo-IsdE of S. aureus and apo-myoglobin, as indicated by the absence of peaks of apoIsdE or holo-myoglobin after holo-IsdE was incubated with apo-myoglobin. In line with these
observations, Stillman and colleagues have suggested that productive protein-protein interactions
enable heme transfer from one protein to another (55).
In the C. diphtheriae system, the heme uptake protein HtaA-CR2 is very stable, with the
half-life of 5 h in 6.8 M GdnHCl at 37 °C (1). Dixon and colleagues argue that the significant
stability of HtaA-CR2 is presumably due to the requirement of specific protein-protein
interaction with its natural heme-accepting partner for transfer of the heme.
Maresso and colleagues have suggested that the transfer of heme from the NEAT protein
BslKN to IsdC in the Bacillus anthracis is facilitated by protein-protein interactions (65). No
heme gain or loss was observed between holo-BslKN and apo-myoglobin, as indicated by no
spectral changes for either the holo- or apo-protein after 24 h of incubation. However, incubation
of holo-BslKN with apo-IsdC resulted in a Soret similar to the as-isolated holo-BslKN. Maresso
has taken these data to indicate that specific interaction between the two natural partners enables
the heme transfer between these proteins.
Lei and colleagues have proposed that the molecular mechanism of heme transfer
between holo-Shp and apo-HtsA in S. pyogenes is facilitated by complex formation between the
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two proteins (Kd of 48 ± 0.7 𝜇M)(66). In holo-Shp, mutation of the axial ligand M66A but not
M153A increased the binding constant between the two proteins (Kd of 11.4 ± 0.3 𝜇M). In line
with these observations, Lei and colleagues suggested that apo-HtsA must be in close proximity
to the two axial ligands of holo-Shp (66). An X-ray structure showed that the heme and its
binding sites in the Shp were exposed to the solvent (67). This is consistent with the proposition
of Ran et al. that the heme pocket of apo-HtsA changes conformation after complex formation,
allowing insertion of its ligands on both sides of exposed heme and simultaneously extracting it
from holo-Shp (66).
Other studies have also led to the conclusion that heme transfer between natural partners
is facilitated via specific protein-protein interactions. These examples include investigations of
the pathways in Isd proteins of S. aureus from IsdAN to IsdCN (68); B. anthracis from IsdX1/
IsdX2 to IsdC (69); and from Hbp1 to Hbp2 in L. monocytogenes (70).
1.9

Heme-iron uptake strategies
A second look at the known HtaA- and NEAT-based heme uptake strategies shows that

most of the proteins involved in the first step have at least two conserved domains. One
possibility is that multiple proteins are required for efficient transfer of heme. In certain
instances, it is known that one domain binds the protein that donates heme, and the other extracts
the heme. An example is the approach employed by the NEAT domains of S. aureus described
above. IsdHN2 binds both Hb and the Hb-Hp complex (38, 39, 42), but not heme itself, and
IsdHN3 domain binds heme (71), but not Hb (39). IsdBN2 binds both Hb and the Hb-Hp complex
whereas, IsdBN1 binds neither of these sources but does bind heme (44).
A similar strategy may be occurring in C. diphtheriae HtaA, which can bind both Hb and
the Hb-Hp complex. HtaB can receive heme from both HtaA and Hb, but cannot itself bind Hb
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(8). The necessity for one domain to bind the heme donor and the second to receive the heme
leads to the assumption that they are in close proximity. In some instances, both domains are part
of the single protein.
As described in detail above, it is also the case that ChtA and ChtC work in concert with
one another to utilize the Hb-Hp complex iron (36). As described in detail above, Schmitt and
colleagues have proposed that ChtA and ChtC work in concert with one another to utilize the
Hb-Hp complex iron (36). This was consistent with the finding that mutation of two genes, chtA
and chtC, but not only chtA or chtC, abolished the bacterial growth in the presence of the Hb-Hp
complex.
Two domains may also serve to take up and store heme, as has been proposed for Shr
from S. pyogenes (61). For this system, the kinetics of heme uptake have been interpreted in
terms of heme transfer to ShrN1, with ShrN2 serving as a heme storage domain. The second
domain can transfer heme back to the first for movement along the pathway when the exogenous
heme level drops.
1.10 Purpose of Study
Due to constant evolving antibiotic resistance, new ways of controlling bacterial
infections are urgently needed. In hopes of developing alternative antibiotic therapeutics, it is
useful to study heme uptake in heme proteins.
Most of the heme uptake work has been performed Gram-negative bacteria. These
studies focus mainly on the strategies used by Gram-positive bacteria for heme uptake. In the
first project, characterized the heme-binding proteins ChtA from C. diphtheriae. Spectroscopic
techniques were used to determine some biochemical and biophysical characteristics of this
protein.
13

Chapter 2 is a draft of the manuscript entitled “Characterization of homologous heme
uptake proteins HtaB, ChtB, and ChtA from Corynebacterium. diphtheriae," which is to be
submitted to a peer-reviewed journal . Chapter 3 is the additional experiments that are not part of
the manuscript.
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Table 1.1 C. diphtheriae proteins and mutants binding studies.
HtaA

Heme
1.9 µM

HtaA-CR1

WT>H107A>Y49A

HtaA-CR2

WT>Y490A>H412A≈
Y361A>Y361/Y412A

HtaA mutants
Y49A

Hb
0.28 µM
WT>>>>H107A≈Y49A

WT>Y49A>>Y361A>>
Y361/Y49A

WT>Y490A>H412A≈Y361A

WT>Y49A>>>Y361A>>
Y361/Y49A

Y490A

WT>Y490A>H412A≈Y361A

WT>Y490A>H412A>
Y361>>>Y361/Y412A

Y361/Y49A

No binding

CR2Y361A

WT>Y490A>H412A>
Y361>>>Y361/Y412A

CR2Y361/Y412A

WT>Y490A>H412A≈
Y361A>Y361/Y412A

No binding

CR1Y49A

WT>H107A>Y49A

No binding

CR1H107A

WT>H107A>Y49A

No binding

HtaB

4.9 µM

-

ChtB

abs 405 nm (0.02-no hemin)
Rel 0.10

0.51 µM

abs 405 nm (0.02-no hemin)
Rel 0.16
Rel 0.10

0.41 µM
0.24 µM

Y129A
Y178A
Y178H

370 nM
200 nM

Y361A

ChtA
ChtA-CR
ChtA mutants

Hb-Hp
210 nM

Rel 0.08
Rel 0.06

ChtC

No
binding

270 nM

> 2 µM
890 nM

abs 405 nm (WT-1.1)
Rel 0.2
Rel 0.2
Rel 0.4
0.52 µM

References taken from, (8, 28, 34, 36).
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Table 1.2 C. diphtheriae growth studies.
Hb
OD600 nm

Hb-Hp
OD600 nm
References

WT

Rel 1.5

(34)

HtaA-CR
mutants
AY49A
Y361A

Rel 1.3
Rel 0.9

(34)
(34)

Y490A
Y361/Y49A

Rel 1.0

(34)

WT
△HtaA
△ChtC
△HtaA/ChtA/C
△ChtA/B

Rel 0.96
Rel 0.5
Rel 0.88
Rel 0.96
Rel 0.46
Rel 0.76

(8)
(8)
(8)
(8)
(8)
(8)

△htaB/chtB
△htaB
△chtB
WT

Rel 0.58
Rel 0.83
Rel 0.75
Rel 2.5

(8)
(8)
(8)
(36)

Rel 1.6

(36)

△htaA
△htaB
△chtA
△chtC
△chtA/C
△htaA/chtA/C

Rel 1.4

(36)

Rel 0.2

(36)

Rel 2.5
Rel 2.4
Rel 2.5
Rel 1.4

(36)
(36)
(36)
(36)

Rel 1.0
Rel 1.0
Rel 0.2
Rel 0.05

(36)
(36)
(36)
(36)

△ChtA/B/C
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Figure 1.1 Medically important Gram-positive Bacteria: Actinobacteria (HtaA domains)
and Firmicutes (NEAT domains).
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Figure 1.2 Clustal Omega alignment of NEAT domains for IsdB, IsdC, IsdH, and nonNEAT domain, IsdA from S. aureus; NEAT domains for Shr and non-NEAT domain, Shp
from S. pyogenes.
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Figure 1.3 A graphical sequence Logo representation of HtaA family (PF04213)
generated by profile Hidden Markov Model (pHMM): Y15, H15, and Y148 are
equivalent to Y1, H, and Y2, respectively of HtaA-CR2 from C. diphtheriae (1).
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Figure 1.4 The model of the location of the Isd proteins involved in heme
import into S. aureus (5).
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Figure 1.5 The model of the location of proteins involved in heme import
into S. pyogenes (12).
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Figure 0.1 The crystal structure of intact Hb with IsdHN2N3. D: The IsdHN2 domain
binding 𝛽-Hb (green), and E: the IsdHN3 positioned near the heme of the 𝛼-Hb (blue).
PDB 4IJ2 (10).
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Figure 0.2 Heme binding including the axial Y and its H-bonding partner in
IsdA, IsdC, and IsdH (9)
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CHARACTERIZATION OF HOMOLOGOUS HEME UPTAKE PROTEINS HTAB,
CHTB, AND CHTA FROM CORYNEBACTERIUM DIPHTHERIAE
This chapter is a draft of the manuscript to be submitted to a peer-reviewed journal. The

authors are Catherine Odhiambo a, Rizvan C. Uluisik a, Brandon L. Ferrell a, Gudrun S. LukatRodgers b, Courtni E. Allen c, Michael P. Schmitt c, Kenton R. Rodgers b, *, and Dabney W.
Dixona *. The expression, purification, and UV-visible spectroscopy of the WT and mutants were
performed at Georgia State University.
2.1

Introduction
Corynebacterium diphtheriae is a Gram-positive bacterium that causes communicable

infections of the upper respiratory tract and skin in humans. Strains that secrete the iron- and
DtxR-regulated diphtheria toxins are associated with severe symptoms (35, 72). Early work
showed that strain C7 was able to use both heme and hemoglobin as iron sources in a low-iron
medium (73). A screen for heme- and hemoglobin-uptake-deficient mutants discovered a gene
cluster expressing a heme transport-associated protein HtaA and a heme-binding protein
(HmuT), which transfers heme to HmuUV, an ABC transporter (20). Two additional gene
products, HtaB and HtaC, were also expressed from this gene cluster, each transcribed from its
own DtxR promoter (28, 29). In later work, two more operons transcriptionally regulated by
DtxR and iron were discovered, with gene products ChtA-ChtB and ChtC-CirA (74).
HtaA, HtaB, ChtB, ChtA, and ChtC (Figure 2.1) all have heme-binding domains that
show significant sequence similarities (Figure 2.10). HtaA has two of these conserved domains,
and the other four proteins each have one. There are two highly conserved tyrosines, one about
ten resides from the N-terminus (Y1), and the second about 30 residues from the C-terminus of
the domain (Y2). There is also a histidine or tyrosine about one-third of the way through the
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sequence. For the second conserved domain in HtaA (HtaA-CR2), Y1 is more important for
hemin binding Y2, but both are involved in some way (74, 75). Biophysical studies have showed
that the heme has a tyrosine ligand (75).
HtaA, ChtB, ChtA, and ChtC all bind Hb with similar binding constants (74). Heme can
be transferred from Hb to HtaA and from HtaA to HtaB (28, 34). HtaB can acquire heme from
Hb but cannot itself bind Hb (74).
The Hb-Hp complex may also be a major source of heme iron for bacterial pathogens;
almost all free Hb is found in the Hb-Hp complex in vivo (76). In for these C. diphtheriae
proteins, HtaA takes up the heme from Hb-Hp in conjunction with ChtA and ChtC (which seem
to have very similar functions) (11).
Recent structural studies on three conserved domains in the related species,
Corynebacterium glutamicum (CgHtaA-CR1, CgHtaA-CR2 and CgHtaB), have shown that the
heme is positioned on edge of the protein cleft below a short 𝛼-helix (4). In these domains Y1
serves as the axial ligand and Y2 forms a hydrogen bond with a heme propionate. A conserved
serine near the N-terminus forms a hydrogen bond with the same propionate. The conserved
histidine forms a hydrogen bond with Y1 as well as another tyrosine.
Biophysical studies to date on the C. diphtheriae HtaA pathway have concentrated on
HtaA (28, 34, 75) and HmuT (63, 77, 78). Herein we report the characteristics of an additional
three members of this multifaceted heme uptake pathway. We first compare the properties of
HtaB and ChtB, which seem to be able to function for one another in vivo (74). ChtA, which
appears to be required for heme uptake from Hb-Hp (11), is then discussed.
Resonance Raman (rR) spectroscopy was used to investigate the structural and electronic
features of the heme micro-environment in the binding pocket. The stability of the protein
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folding was investigated via chemical and thermal denaturation techniques and collision-induced
heme dissociation in the gas phase. We compare the C. diphtheriae proteins with those of C.
glutamicum. These comparisons within and between species lead to a picture of related proteins
that are similar in many aspects, but nonetheless have noticeable differences, presumably
significant in controlling the process of heme transfer. This work adds to the increasing
knowledge of heme uptake in Gram-positive pathogenic bacteria across a variety of species as
outlined in recent reviews (15, 79-83). Most pathogenic bacteria need iron for survival. A deeper
understanding of the role of hemin uptake in providing this iron (84) may point to new
approaches to the increasing problem of bacterial resistance to antibiotics (85).
2.2

Experimental
2.2.1

Reagents and solutions

Buffer A was 100 mM Tris-Cl and 150 mM NaCl at pH 8.0. Buffer B was 100 mM TrisCl, 150 mM NaCl, and 2.5 mM d-desthiobiotin and 1.0 mM of EDTA, pH 8.0. Buffer C was a
mixture of 50% Buffer A and 50% Buffer B. Buffer D was a mixture of 30% Buffer A and 70%
Buffer B.
2.2.2

Optical spectroscopy

UV-visible absorbance spectra were recorded either with a single beam (Varian Cary 50
Bio) or a dual beam scanning spectrophotometer (OLIS-14). The measurements were made using
quartz cuvette having a 1.0 cm path length. HtaB, ChtB, ChtA and, HtaB Y56A, H121A
concentrations were calculated from ε280 from ExPASY: 42,985, 46,535, 25,485, 41,495 and,
42,985 M-1 cm-1, respectively. Hemin (Sigma-Aldrich) concentrations in dimethyl sulfoxide
(DMSO) were calculated using ε624 = 6.23 mM-1 cm-1 (64). MetHb (equine, Sigma-Aldrich)
concentrations were calculated using ε409 = 179 mM-1 cm-1 (86). The Sephadex G25 medium and
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superfine grades were from GE Healthcare. The pyridine hemochrome assay was used to
determine the extinction coefficients (87). An average of three experiments gave an extinction
coefficient of 1.3 x 105 M-1 cm-1 for HtaB-WT, 1.1 x 105 M-1 cm-1 for ChtB, and, 1.4 x 105 M-1
cm-1 for ChtA.
2.2.3

Circular dichroism

Circular dichroism (CD) spectra were recorded using a Jasco J-810 spectropolarimeter
using quartz Suprasil cuvettes with a 1 mm. Protein samples were recorded in 10 mM KH2PO4
buffer at pH 7.0; concentrations were adjusted to 10 µM, except that a Jasco J-1500 CD
spectropolarimeter and a quartz cuvette having a 1.0 cm path length was used for ChtA with a
protein concentration of 1.5 µM in Buffer A. The final spectra represent an average of 20 scans.
2.2.4

Constructs

The ChtB and ChtA constructs have been previously described (74). For HtaB-WT, an Nterminal Strep-tag labeled construct was synthesized and inserted into pET24a(+) plasmid at the
NdeI and HindIII restriction sites. The construct included the peptide sequence between Ala25
and Asn292 (NCBI sequence reference number WP_004566989.1). A TEV cleavage sequence
was inserted between the Strep-tag and HtaB-WT. A linker sequence of SGGGGG was used to
separate the Strep-tag and the TEV cleavage sequence. Primers are given in Table 2.2.
2.2.5

Site-directed mutagenesis

Two mutants of HtaB were prepared by site-directed mutagenesis using a QIAprep Spin
Miniprep Kit according to the manufacturer’s instructions. The primers were from Sigma
Aldrich for Y56A and H121A substitutions (Table 2.2). Primers (500 ng) were mixed with 100
ng of pET24a(+) template plasmid in the reaction mixture. DpnI restriction endonuclease was
used to remove the methylated template. The plasmids were isolated from the reaction mixture
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and transformed into competent Escherichia coli strain BL21(DE3) cells. Sequence analysis was
used to confirm the mutations.
2.2.6

Sequence alignments and homology Modeling

Sequence alignments were performed using the Clustal Omega software from the
European Bioinformatics Institute (EMBL-EBI) database. The C. diphtheriae proteins HtaB,
ChtB, and ChtA, HtaA-CR1, and HtaA-CR2 were aligned with the conserved regions of HtaACR1, HtaA-CR2 and HtaB from C. glutamicum (4). Homology models were constructed using
the I-TASSER software (88)
2.2.7

Expression and purification

The protocol for HtaB is given in detail. Luria-Bertani (LB) medium was used for
culturing the E. coli cells. The medium contained 50 µg/ml kanamycin with 0.3% glucose. A
small-scale culture (10 ml) was incubated at 37 oC/220 rpm for 16 h, added to 990 ml of media
and the resulting solution incubated at 37 oC/220 rpm until the OD600 reached 0.8. The cultures
were induced by adding 50 µM isopropyl-β-D-thiogalactopyranoside (IPTG) and allowed to
express for 16 h. The cells were harvested by centrifuging at 8000 rpm/4 oC for 30 min. The
pellets were collected and stored in -20 oC freezer overnight.
The cell pellet was re-suspended in buffer A. The cells were lysed in a solution
containing buffer A, 10 mM MgCl2, 0.1 mM phenylmethanesulfonyl fluoride (PMSF), 0.2
mg/mL lysozyme, 5 μg/mL DNase I (from bovine pancreas, Roche) and 5 μg/mL RNase A (from
bovine pancreas, Roche) and incubated on ice for 30 min. The cells were disrupted with a
sonicator, and the cell debris was removed by centrifugation at 6500 rpm/4 oC for 45 min.
A GE Healthcare ÄKTA fast protein liquid chromatography instrument (FPLC) was used
for purification at 4 oC. The protein solutions were loaded onto a Strep-Tactin Superflow column
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(5 mL, IBA BioTAGnology) which had been equilibrated with Buffer A. The unbound material
was washed out with 5 column volumes of Buffer A. The Strep-Tactin bound protein was eluted
with 10 column volumes of Buffer B. A linear gradient of buffer A and B was used. The purity
of the fractions was tested by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDSPAGE). Approximately 0.8 mg/L of protein were isolated. The hemin loading was 30%. The
HtaB Y56A, H121A, and ChtB were prepared in the same manner.
ChtA was prepared similarly except that Terrific Broth was used with 0.3 mM of IPTG
and no glucose. Expression was for 3 h at 37 °C.
2.2.8

Hemin addition

HtaB (14.2 µM) with 30% hemin loading as isolated, prepared in Buffer A, was used for
hemin titration. Aliquots of a solution of 4.63 mM hemin in DMSO were added to the protein
sample which was allowed to incubate for 30 min after each addition. UV-visible spectra were
recorded after each hemin addition up to a hemin:protein ratio of 0.90. The volume of DMSO in
solution did not exceed 0.2%.
The HtaB Y56A and H121A (both approximately 4% hemin loading as isolated) hemin
addition experiments were performed identically on the concentrations of 15.2 and 21 µM,
respectively.
The hemin loading of as-isolated ChtB (60%) was sufficient for spectroscopic
experiments.
ChtA (28.1 µM) initially 20% heme loaded (Soret:280 nm ratio of 0.29) in Buffer A, was
used for hemin reconstitution. Addition of one equivalent of hemin in DMSO gave a sample that
was passed down a Sephadex G25 superfine column three times.
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2.2.9

Hemin transfer from metHb

HtaB (23.8 µM, 3.8 ml), 30% hemin loading as isolated, prepared in 100 mM Tris-HCl
with 150 mM NaCl at pH 8.0, was used for metHb-hemin reconstitution. The protein solution
was loaded onto a Strep-Tactin column (5 mL IBA BioTAGnology). A Hb (59.9 µM, 5 mL)
solution in the same buffer was loaded onto the column. The column was washed with Buffer A
to remove excess Hb. Spectra of the eluent fractions showed that all free heme-containing
species had been washed from the column. The column was held at 4o C for 20 h. The columnbound HtaB-WT was eluted using 10 column volumes of Buffer B. The hemin-bound fractions
of HtaB-WT were concentrated using an Amicon Ultra-15 centrifugal filter at 6500 rpm and 4o
C.
The HtaB Y56A mutant and ChtB Hb-hemin addition experiments were performed
similarly except that Hb (100 and 503 µM) was used on the protein concentrations of 39 and 76
µM, respectively.
2.2.10 Time scale of unfolding
A solution of HtaB-WT (14.7 µM) and 4.0 M GdnHCl was prepared in Buffer A. The
GdnHCl concentration was determined by the refractive index method (89). The solution was
stirred for 10 min at 25 oC. The UV-visible spectrum was monitored over time for 18 h at 25 oC.
The absorbance at 409 nm was fit to a single-term exponential function using Kaleidagraph
(version 4.01, Synergy Software).

𝐴$ = (A0−𝐴% )exp(−𝑘& 𝑡 +𝐴% )
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where 𝐴$ is the absorbance at any time during the unfolding reaction, A0 is the initial
absorbance, 𝐴% , is the absorbance of the completely unfolded protein, A0−𝐴% , is the total ∆𝐴 for
complete unfolding, and 𝑘& is the unfolding rate constant.
The ChtB and ChtA unfolding experiments were run similarly on the concentrations of
15.8 and 18.5 µM, respectively.
2.2.11 Thermal denaturation
Thermal unfolding of HtaB (2.76 µM) was carried out with the UV-visible
spectrophotometer equipped with temperature control (TC 125, Quantum Northwest). A screw
top quartz cuvette with 1 cm path length was used. The protein solution was prepared in 50 mM
NaH2PO4, pH 7.0 buffer including 1.0 M GdnHCl. Data at 410 nm were recorded every 1°C
after a 1 min incubation at each temperature. Kaleidagraph was used to fit the data using a twostate protein unfolding model equation (90): Eq. (1)

A=

(A' + 𝑚' T) + (A( + 𝑚( T)𝑒𝑥𝑝 B
1 + 𝑒𝑥𝑝 B

∆𝐻)
E
− T "# )

"#
𝑅(T)

∆𝐻)
E
− T "# )

"#
𝑅(T)

where A is the absorbance at any point along the unfolding curve, AF is the absorbance of
the folded state, A( is the absorbance of the unfolded state, mF is the slope of the folded state, mU
is the slope of the unfolded state, Tm is the temperature at which the protein is half unfolded, ΔHm
is the enthalpy of unfolding, R is the gas constant, and T is the temperature (Kelvin).
The HtaB Y56A, H121A and ChtB unfolding experiments were run in a similar fashion
on concentrations of 2.44, 8.33, and 5.35 µM, respectively.
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The ChtA experiment was run on the concentration of 10 µM. However, the protein was
not stable in 50 mM phosphate, so a solution of 1.5 M GdnHCl in Buffer A was used.
2.2.12 Electrospray ionization (ESI) mass spectrometry
ESI spectra were obtained using a Waters Micromass Q-TOF spectrometer in the positive mode.
The fully holoprotein samples (HtaB-WT, HtaB H121A, and HtaB Y56A) were prepared by
adding of hemin to the as-isolated protein (approximately 30% heme loaded) as previously
described. The protein solutions (~10 µM) were dialyzed against 20 mM ammonium acetate, pH
6.8. Spectra were recorded (flow rate 10 µl/min) for each sample at the following collision
energy voltages: 5, 10, 15, 20, 25, 30, and 40 V. All other parameters were held constant
(capillary voltage 3000 V, cone voltage 18 V, extraction voltage 1.5 V, desolvation gas
temperature 100 oC and source temperature 80 oC). Deconvolution of the charged state was
performed using the MaxEnt program with the MassLynx™ software. Peaks were rounded to the
nearest Dalton; peak heights were used to calculate holoprotein percentages at each collision
energy voltage.
2.2.13 Resonance Raman (rR) spectroscopy
Resonance Raman (rR) spectra were recorded from ferric samples using the 413.1-nm emission
line from a Kr= laser and from ferrous samples with 441.6-nm excitation from a HeCd laser. The
Raman shifts for toluene, DMSO, and methylene bromide were used as external standards for
spectral calibration. Spectra were recorded at ambient temperature using the 135° backscattering
geometry with the laser beam focused to a line on a spinning 5 mm NMR tube. UV−visible
spectra were recorded before and after rR experiments to verify that the samples were not altered
by their exposure to the laser beam. The buffers used were 100 mM glycine (9.6), Tris-HCl (pH
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8.8 or 8.0), and sodium phosphate buffer (pH 5.8). Ferrous samples were prepared under
anaerobic conditions by adding buffered dithionite in a 300-fold molar excess over heme. The
Fe(II)-CO samples were prepared with a 300-fold molar excess of dithionite under an
atmosphere of natural abundance CO or 13CO at pH 8.8. The final protein concentrations were 30
µM for the HtaB-WT.
2.3

Results and Discussion
2.3.1

Homology modeling

Homology models were built based on the recent structures from C. glutamicum (4).
Figure 2.2 shows the models for ChtA and ChtB. In ChtA, the model shows the important
residues around the heme including the axial tyrosine Y129, the two residues that forms a
hydrogen bond with one of the propionates, Y272 and S125, and a phenylalanine that stacks
against the heme F271. When heme is bound, Y129 is presumably forms a hydrogen bond with
H279 which is in turn hydrogen bonded to Y178. In this model, these three residues are extended
away from the heme pocket. Disruption of the Y129-H279-Y178 triad may be an important
triggering factor in heme transfer.
ChtB has a less well-defined β-sheet structure on one side of the heme. Y56 is the axial
ligand hydrogen bonded to H121. Y223 and S52 are hydrogen bonded to the heme propionate.
All of the structures in the HtaA family show significant overall similarities, with a heme
lying between two α-helices, and an axial tyrosine hydrogen bonded to a histidine. A serine four
residues away from the axial tyrosine forms a hydrogen bond with one of the heme propionates.
Interestingly, this motif is also found in NEAT, another major heme uptake domain (Andrade et
al., 2002; Grigg et al., 2011; Honsa et al., 2014). Presumably as the protein docks with its
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transfer partner, changes in these hydrogen bonding networks allow the heme to be released from
the pocket.
2.3.2

UV-visible spectroscopy, heme addition, and pH titrations

Despite the presumed similarities between HtaA (homologous to ChtA/ChtC) and HtaB
(homologous to ChtB), these proteins vary greatly in how heme loaded they are as isolated. The
goal of this work was to determine whether the reconstituted protein was similar to those as
isolated.
HtaB-WT was usually only about 30% heme loaded as isolated. The UV-visible spectrum
shows a Soret band at 408 nm, 𝛽 and 𝛼 bands at 504 and 542 nm, respectively, and a chargetransfer band at 625 nm (Figure 2.3). The charge-transfer band is consistent with a high spin
heme-iron interaction with an oxygen species, often seen in tyrosine-coordinated heme proteins
(82, 91).
To increase heme loading, hemin in DMSO was titrated into the solution to a total of 1
equivalent of hemin. The final ASoret:A280 ratio was approximately 1.8. The spectra of the asisolated and hemin-titrated HtaB-WT (Figure 2.11). were similar, suggesting that the added
hemin was in the same environment as that found in the as-isolated protein. The heme loading of
HtaB-WT was also increased by transferring the hemin from metHb. This spectrum also was
very similar to the previous two (Figure 2.11). The strategy of transferring hemin from Hb to
tagged protein may prove to be a useful technique for heme transfer under mild conditions.
The HtaB as-isolated breadth was slightly wider, indicating the heterogeneity in the asisolated heme pocket.
Two HtaB mutants were studied. Y56A and H121A were isolated with less than 5%
hemin loading, far less than WT (30%). For H121A, the spectrum of the as-isolated protein
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(Figure 2.4) was very similar to that of wild type (Figure 2.3).These data argue that H121 is not
an axial ligand of the heme in this protein. Hemin in DMSO was added up to a total of 1 eq
hemin. The resulting spectrum was similar as that of the as-isolated H121A (Figure 2.12).
For Y56A, in contrast, the as-isolated protein (only 5% heme loading) had a very
different spectrum (Figure 2.13) from that of the WT. The 542 and 625 nm peaks disappeared,
while new bands appeared at 547 and 587 nm. The lack a charge transfer band at approximately
625 nm is consistent with a heme that does not have a tyrosine axial ligand.
HtaB Y56A was reconstituted both with hemin and by transferring hemin from metHb.
The spectra of the resulting species were similar to one another and WT HtaB (Figure 2.13). As
the presumed axial Y56 is no longer present, these spectra may indicate a conformational change
to provide another oxygen-coordinated axial ligand, presumably another tyrosine or water.
In contrast to HtaB, ChtB was 60% heme-loaded as isolated; the spectrum was very
similar to that of HtaB-WT (Figure 2.2). Addition of hemin via transfer from hemoglobin gave
holo protein with the same spectrum as the as-isolated species (Figure 2.14).
ChtA had less than 5% bound hemin as isolated. When 0.9 eq of hemin in DMSO was
added to a protein sample that was already 30% heme loaded, a broad Soret band was observed
(Figure 2.15). Passing this sample through a Sephadex G25 superfine column resulted in a
narrower Soret, but the band was still broader than those of the other conserved domains in this
family (Figure 2.15). To determine if the breadth of the ChtA peak was due to remaining surfacebound hemin, the sample was passed through the Sephadex G25 superfine column twice more.
Minimal changes were seen (Figure 2.15), leading to the conclusion that the Soret of ChtA is
intrinsically broad. Comparison of the reconstituted proteins to HtaA-CR2 (75), were very
similar (Figure 2.2).
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pH titrations of ChtA, HtaB-WT and ChtB showed no significant spectral changes over
the pH range 6.9-11.2 (data not shown). These findings are in line with the previous observation
that HtaA-CR2 shows no pH-induced changes over this range (75).
2.3.3

Hemin transfer between HtaB and ChtB

Growth studies show that either HtaB or ChtB can serve in terms of the growth of the cell
with heme as an iron source (28, 74). It was of interest to determine whether HtaB and ChtB
could transfer hemin between them. Previous studies showed that holo HtaA can transfer a heme
to HtaB (34). This has been the only transfer shown thus far in the hmu-cht heme uptake
pathway. HtaB and ChtB both have significant sequence similarities, suggesting that the proteins
may have similar functions as intermediate transport proteins.
To assess heme transfer between HtaB and ChtB, heme-loaded strep-tagged ChtB was
bound to a StrepTactin column and incubated with as-isolated His-tagged HtaB. The proteins
were separated by washing the column with buffer A to elute all His-tagged HtaB followed by
the elution of strep-tagged ChtB with a linear gradient of buffer B. The fractions were collected,
concentrated, and assessed for purity by SDS-PAGE; only one protein per fraction data not
shown. The UV-visible spectra of as-isolated ChtB before and after the transfer are shown
overlaid in Figure 2.9. The results show that HtaB and ChtB readily transfer heme to one another
(Figure 2.9). This indicates that there may be an extent of crossover of heme transfer between the
hmu and cht heme uptake pathways in vitro.
2.3.4

Resonance Raman spectroscopy of ferric WT HtaB and ChtB

The rR spectrum of ferric HtaB is pH independent, as evidenced by the unchanging highfrequency spectrum over the pH range from 5.8 to 9.6 (Figure 2.5). The n3, n38, and n2 core
stretching frequencies of 1483, 1520, and 1561 cm−1, respectively, reveal the heme to be in a 636

coordinate high spin (6cHS) state (7). Another protein in a heme uptake pathway, Yersinia
pseudotuberculosis (Yp) HasA, has been shown to exist as an equilibrium mixture of 6cHS and
5-coordinate high-spin (5cHS) states (92), the former presumably having with a water molecule
as the sixth ligand (Table 2.1). YpHasA also does not show a pH dependence over the pH range
from 5 to 10. Serratia marcescens (Sm) HasA (93) and CdHmuT are mixtures of 6cHS and 6
coordinate low-spin (6cLS) states (77). Even though the CR domain of HtaB shares
approximately 27% sequence identity and 38% similarity with the CR2 domain of HtaA, the
hemin binding motifs are distinct because CdHtaA is 5cHS in the ferric form (75). HtaA exhibits
a rR spectrum typical of 5cHS hemin that is bound to the protein through a proximal tyrosine
ligand. The n3 (1490 cm−1) and n2 (1568 cm−1) rival the intensity of the n4 which is unusual for
other hemin proteins but has been observed in bovine liver catalase (94) and Shigella dysenteriae
ShuT (95), both of which share the proximal Tyr binding motif as seen in Table 2.1.
Like its HtaB homolog, CdChtB forms a 6cHS hemin complex with spectral
characteristics consistent with a proximal Tyr binding motif (Figure 2.6).The n3, n38, and n2 core
stretching frequencies of 1486, 1522, and 1560 cm−1, respectively, indicate 6cHS hemin (7).
Unlike ferric HtaB, peripheral substituent modes in ChtB exhibit slight pH dependences, as seen
in the shifts of the in-plane vinyl stretch from 1613 to 1627 cm−1, the in-plane CbCb stretch from
1560 to 1558 cm−1, the in-plane pyrrole breathing mode from 761 to 754 cm−1, out-of-plane
pyrrole fold from 739 to 735 cm−1 and an increase at 666 cm−1, and out-of-plane wags from 329
to 327 cm−1 and from 311 to 308 cm−1 Figure 2.6 and 2.16. None of these vibrations are
particularly sensitive to the coordination number or spin state of the heme, as evidenced by the
constancy in the n4 and n3 frequencies among these proteins. This indicates that the structural
determinants for coordination number and spin state in the hemin binding pockets of HtaB and
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ChtB are similar, with the environments that impact conformations of the peripheral substituents
being slightly variable.
2.3.5

Resonance Raman spectroscopy of ferrous HtaB

Upon reduction with dithionite, HtaB was converted to a mixture of 5cHS and 6cLS
ferrous states. This mixture was revealed by a n3 band at 1468 cm−1 and a small band at 1494
cm−1, respectively Figure 2.17. The n11, n2, and n10 core stretching frequencies of 1558 cm−1,
1583 cm−1 and 1624 cm−1 respectively, are consistent with the speciation being dominated by the
5cHS heme state (96); the UV-visible Soret maximum of 428 nm is also consistent with this
assignment. This result differs from both YpHasA, which is solely 5cHS (n3, 1470 cm−1), and
CdHmuT and SmHasA, which do not form ferrous complexes under similar conditions (77, 92,
93).
The rR spectra are also consistent with the UV-visible Soret maximum of 428 nm,
suggesting a predominately 5cHS speciation similar to what was reported for YpHasA (92)
(Figure 2.17, inset). When excited with the 441.6-nm laser light, the low frequency spectrum of
HtaB contains a small band at 217 cm−1, which is a typical FeII-His stretching frequency in 5cHS
ferrous heme proteins (Figure 2.7). Because of its red-shifted Soret band, blue (441.6 nm) Raman
excitation selectively enhances Raman scattering by the modes of 5cHS having a proximal His
ligand. Thus, it is possible to detect the presence of axial His ligation in 5cHS ferrous hemes,
even if it is not the majority species (97).
It is possible that a His ligand is replacing the axial tyrosine in a fraction of the ferrous
form. This type of displacement has been observed for the ferrous form of S. pyogenes NEATA, in which the axial Tyr ligand in the ferric form is replaced by His in the ferrous form of the
protein (98). The small relative intensity of the 217 cm−1 band, in comparison to that of νFe−His
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modes from other proteins, is likely due to a small amount of the protein being 5cHS with the
remainder having Tyr coordinated in the axial position. These spectra suggest the ferrous HtaB is
a mixture of complexes, comprising predominately a 5cHS Tyr complex with small contributions
from a 5cHS His-bound and 6cLS Tyr/X-bound hemes.
Ferrous ChtB was solely 5cHS as evidenced by its n3 at 1468 cm−1 and Soret maximum
of 425 nm (Figure 2.18). The n11, n2, and n10 core stretching frequencies of 1556 cm−1, 1584
cm−1 and 1623 cm−1, respectively, indicate a 5cHS heme environment, similar to the 5cHS
contribution to the ferrous HtaB spectrum. The absence of bands attributable to a 6cLS form
indicates that reduction destabilizes its 6cLS heme to an even greater extent than in HtaB.
2.3.6

Resonance Raman spectroscopy of ferrous carbonyl WT HtaB and ChtB

Through the sensitivity of Raman-active Fe-CO group frequencies to p-backbonding and
donor strength of the trans (proximal) ligand, resonance Raman spectra of heme protein
carbonyls are useful probes of both the bonding and non-bonding properties of the heme pocket.
The extent of p-backbonding is evidenced by the νFe−C, νC−O frequencies which, when placed on
a plot of νFe−CO versus νC−O frequencies, yield insight into the electrostatic and steric properties of
the distal heme pocket and the nature of the trans axial ligand (99-102). The Fe−13CO
isotopologs of HtaB and ChtB were used to verify the identity of rR bands corresponding to the
Fe−C stretching (nFe−CO), Fe-CO bending (dFe-CO) and C−O stretching (nC−O) modes, as shown in
Figure 2.19 and Figure 2.20.
Under an atmosphere of carbon monoxide, the UV-visible spectra of ferrous HtaB and
ChtB exhibit shifts of their Soret band maxima to 417 and 415 nm, respectively, along with
sharpening and shifting of the Q bands (insets Figure 2.19 and 2.20). These absorbance changes
are consistent with the formation of the HtaB and ChtB carbonyls.
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The Soret-excited rR spectrum of HtaB−CO reveals two nFe−CO bands at 503 and 532
cm−1, which shift to 501 and 527 cm−1, respectively, upon 13CO substitution. Despite having two
νFe−CO stretches, the spectrum reveals only one nC−O band and a single dFe-CO band at 1949 and
562 cm−1, respectively, which shift to 1902 and 554 cm−1 in the 13CO isotopolog (Figure 2.19)
ChtB−CO also exhibits two nFe−CO bands [503(−3) and 531(−5) cm−1], one nFe-CO band at
563(−13) cm−1 and one nC−O band at 1953(−47) cm−1, similar to what was observed for
HtaB−CO (Figure 2.20). Placement of these pairs of nC−O and nFe−CO frequencies on the pbackbonding correlation plot is consistent with two heme carbonyls having different proximal
ligands (Figure 2.8). One form falls near the line correlating nC−O and nFe−CO of carbonyls having
neutral imidazole ligands. The other falls on the correlation line neutral proximal ligands
coordinated through an O atom. This position is consistent with a proximal Tyr ligand whose
coordinated O atom interacts with a single hydrogen bond donor (vide infra).
The CO ligand in the trans ImH form is in a weak hydrogen bond interaction with the
distal pocket as evidenced by its low position along the neutral imidazole line (103). This
interaction likely involves the native, conserved Tyr56 axial ligand interacting with the
exogenous CO ligand in a manner similar to that reported for CdHmuT mutants R237A and
M292A (63). The position of the form having an O-bound proximal ligand, which is likely the
conserved Tyr56, is indicative of stabilization of the oxygen by a single neutral hydrogen
bonding partner. The position is close to both YpHasA (92) and SmHasA (104) which have been
shown to have a trans neutral histidine that is hydrogen bonded to the axial Tyr (92, 105). The
trans ligand environments of HtaB and ChtB differ from that of CdHmuT, which has been
shown to have a pair of hydrogen bonds from the guanidinium side chain of a nearby Arg residue
(63, 77). The positioning of the Arg hydrogen bonding partner of the Tyr ligand in crystal
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structure of CgHmuT has been shown (78). A possible neutral hydrogen-bonding partner could
be Tyr53 which could stabilize the Tyr56 heme ligand in HtaB, similar to what is seen with IsdB
(45).
2.3.7

Heme dissociation in ESI mass spectrometry

The stability of as-isolated HtaB-WT and its mutants was also evaluated by monitoring
the mass spectra as a function of collision energy (5 – 40 V). Each as-isolated protein was
initially titrated with hemin (~ 0.9 of hemin:apoprotein ratio) to obtain holoprotein
concentrations suitable for the mass spectra experiments. Figure 2.21 shows that the percentage
of holoprotein decreased approximately from 94% to 30% for WT and the H121A mutant.
Y56A, which started with only 67% heme loading, showed a similar loss of hemin with increase
in collision energy. In the gas phase, all three-show comparable heme loss with increasing
collision energy, whereas in the solution phase, the proteins are in the stability order WT >
H121A > Y56A.
This has been observed previously in studies on myoglobin and cytochrome b5 (106) as
well as the HmuT heme transfer protein (63) for which gas phase and solution phase data do not
necessarily show a direct correlation.
2.3.8

Time scale protein unfolding in chemical denaturation

Denaturant-induced unfolding of heme proteins is used to understand the factors that
control heme binding at the active site (89). In previous work, we showed that HtaA-CR2, a
domain with significant sequence similarity to HtaB, was very stable in the presence of GdnHCl;
e.g., a half-life of 330 min was observed even in the presence of 6.8 M GdnHCl at 37 oC (75).
ChtA was less stable than HtaA-CR2; the protein has a half-life of 352 min in the presence of 4.0
M GdnHCl at 25 oC (Figure 2.22).
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HtaB and ChtB were significantly less stable toward unfolding. HtaB showed a single
first-order process with a half-life of 39 min in the presence of 4.0 M GdnHCl at 25 oC. The
unfolding behavior of ChtB was very similar to that of HtaB under the same conditions Figure
2.23.
Although these four domains of proteins in the C. diphtheriae heme uptake pathway are
structurally homologous both in alignment and in the similarity of their spectra, they are quite
different in kinetics of unfolding. HtaB and ChtB have half-lives of approximately 40 min in 4.0
M GdnHCl at 25 oC; ChtA has a half-life of approximately 350 minutes under these conditions,
and HtaA-CR2 has a half-life of 330 min in 6.8 M GdnHCl at 37 oC. The varying difficulties of
hemin release may be important for directing hemin transfer to specific partner proteins in the
pathway.
2.3.9

Thermal stability

The thermal stability of these domains was in line with the order observed in the kinetics
experiments. HtaA-CR2 had a Tm value of 77 °C in 1.5 M GdnHCl (75). ChtA had Tm value of
59 °C at the same concentration of GdnHCl (Figure 2.24). ChtB and HtaB had Tm values of 61
°C in 1.0 M GdnHCl (Figure 2.25).
To probe the contribution of the axial ligands to the stability of HtaB, thermal unfolding
of as-isolated HtaB, and the H121A and Y56A mutants, was performed. In each case, the Soret
absorbance gradually decreased as the temperature increased. The apparent Tm values were 61,
46, and 27 oC (1 M GdnHCl) for WT HtaB, and the H121A and Y56A mutants, respectively
Figure 2.26. Approximately 90% of the Soret absorbances were recovered for the WT and
H121A mutants when the protein solutions were cooled to the initial temperature. In contrast, no
recovery was observed for the Y56A mutant. These studies indicate that both H121 and Y56 are
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playing a role in heme binding. Y56 has a highly significant role, with a Tm more than 30 oC
lower than WT, and no recovery after cooling to room temperature. The importance of these two
residues is in line with the rR back-bonding correlation results showing that HtaB is likely a
Tyr/His heme-coordinated protein.
The very similar data for HtaB and ChtB in terms of thermal stability, as well as the
kinetics of GdnHCl-induced unfolding, are consistent with similar structures and heme binding
sites; it is thus reasonable that they play a similar role in the heme uptake. Indeed, Allen and
Schmitt showed that a single deletion of either htaB or chtB genes does not affect cell growth in
C. diphtheriae, but a double mutation of these genes, significantly affects the growth (28, 74).
The significant differences in ease of unfolding of these four proteins presumably arise
from local hydrophobic, electrostatic and hydrogen-bonding interactions in the heme pocket.
Schmitt and co-workers have shown that HtaA can bind hemoglobin while HtaB does not. HtaA
can transfer heme to HtaB (34). Thus, the presumed pathway for heme uptake involves heme
transfer from HtaA to HtaB/ChtB. It is interesting to note that HtaA-CR2 binds hemin more
tightly (60 nM, Strep-tag) than HtaB (4.9 µM, no tag) in solution (11, 28). Thus, the role of
protein/protein interactions is presumably important in determining the pathway of heme transfer
(75, 77).
2.4

Relationship to other heme uptake pathways
The heme uptake pathway studied herein, based on variations of the HtaACR domain,

can be compared with the well-studied heme uptake strategy that involves NEAT domains (31).
Gram-positive bacteria are largely divided into Firmicutes (low G+C species) and Actinobacteria
(high G+C species). Examples of clinically relevant Actinobacteria include Actinomycetes,
Corynebacterium, Propionibacterium, Rothium, and Streptomycetes. Bioinformatics analysis
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shows that all of these species have sequences homologous to HtaACR. Almost none have
sequences corresponding to the NEAT domain. Examples of clinically relevant Firmicutes
include Bacilllus, Clostridium, Listerium, Staphylococcus, and Streptococcus, all of which use
the NEAT domain, as has been studied experimentally for members of each of these classes (15).
However, almost none of these Firmicutes have sequences homologous to HtaACR. Thus, there
seems to be a divide in the strategies used for the main pathway of heme uptake in clinically
relevant examples of these two phyla of bacteria, with Firmicutes using HtaA domains and
Actinomycetes using NEAT domains. It should be pointed out that the few sequences of NEAT
domains in Firmicutes or HtaACR in Actinobacteria found via a BLAST search may not produce
viable protein, as detailed for some HtaACR homologues in Corynebacterium (74).
Comparison of the known HtaA- and NEAT-based heme uptake strategies shows that
many of the proteins involved in the first step have two copies of the conserved domain. This
design may serve in more than one context. In some instances, one of the domains serves to bind
the protein donor, while the second receives the heme. This has perhaps been studied in the most
detail for the IsdH system of Staphylococcus aureus. The second NEAT domain of IsdH
(IsdHN2) (15, 38, 107) binds both Hb and the Hb-Hp complex (38, 42), but not heme itself (107).
The third (IsdHN3) domain binds heme (Kd, 0.32 µM) (43) but not Hb (107). A crystal structure
of intact Hb with four IsdHN2N3 shows the IsdHN2 domains each binding one of the Hb chains,
while the IsdHN3 are each positioned near the corresponding heme (10). Thus, extraction of heme
from Hb via IsdH seems to require two NEAT domains, one to bind the Hb and the second to
receive the heme. A similar strategy may be occurring in C. diphtheriae; HtaB, which can
receive heme from HtaA, cannot itself bind Hb.
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Two domains may also serve to take up and store heme, as has been proposed for Shr
from S. pyogenes (108). For this system the kinetics of heme uptake have been interpreted in
terms of heme transfer to ShrN1, with ShrN2 serving as a heme storage domain, which can transfer
heme back to ShrN1 for movement along the pathway when the exogenous heme level drops.
In C. diphtheriae, HtaA can use heme from both hemoglobin and myoglobin (1, 11).
However, heme in the Hb-Hp complex can be extracted only when both HtaA and either ChtA or
ChtC are available (11). This is a variation of the ‘two domains in a single protein” motif and
indicates that HtaA and ChtA/C are probably located near one another in three-dimensional
space.
In a few instances, the pathway of heme transfer has been described in detail. In NEATbased systems, kinetic analysis of transfer from IsdA to IsdC to IsdE in S. aureus has been
interpreted in terms of a “cog-wheel” mechanism, in which heme must be moved to IsdE before
IsdC can be reloaded (55); related work on this system includes studies from (52, 64, 68). In B.
anthracis, heme is transferred from IsdX1 to IsdC and IsdX2 (69) and BslKN to IsdC (65); in L.
monocytogenes heme is transferred from Hbp1 to Hbp2 (109). In Group A Streptococcus Shr
transfers heme to Shp, with the possibility of an intermediate with axial ligands from both
proteins (110, 111).
For the HtaA pathway in C. diphtheriae, HtaA-CR2 transfers heme to HtaB. It has also
been shown that HtaB and ChtB can substitute for one another (8) and ChtB can transfer heme to
HtaB (this work). In addition, ChtA and ChtC can substitute for one another (11, 74). The HtaA
heme uptake “pathway” is therefore perhaps better envisioned as a series of alternative crossing
paths for heme entry, with the usage of the various options being determined by not only the
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heme source and specific protein-protein interactions, but also the numbers of various protein
species in the membrane as well as their approximation to one another in space.
2.5

Conclusions
Herein, we have investigated HtaB and ChtB from the HtaA heme uptake pathway in C.

diphtheriae. For both of these domains, sequence alignment, UV-visible spectroscopy of WT and
mutants, and the Raman spectra of the WT protein indicate that tyrosine is the heme axial ligand.
A conserved histidine is also in the heme pocket, as indicated by the observation of two species
for the Fe(II)CO species, one with a trans axial histidine and the second with trans oxygenbound ligand. HtaACR domains are significantly stable to unfolding in solution (induced by
either denaturants or temperature), consistent with the hypothesis that protein-protein
interactions are needed to transfer the heme. The gas phase and solution stabilities are not
necessarily related, as observed in other heme protein stability studies.
Bioinformatics analyses of currently available species indicate that many species of
Actinobacteria, in addition to Corynebacteria, use HtaA domains. The conserved (CR) domains
of HtaA-type proteins are increasingly understood as a fundamental heme transfer motif. The
apparently interchangeability of HtaB and ChtB in transferring heme from HtaA/ChtA/ChtC to
HmuT may indicate that heme uptake does not follow a simple linear pathway, but rather
proceeds along a network of pathways, taking advantage of multiple protein-protein interactions,
as well as protein organization in space, to maximize internalization of this important iron
source.
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Table 2.1 HtaB site-directed mutagenesis primers. The mutation sites are shown bold.
Primer Name

Primer sequence (5’-3’)

H121A-Forward

CGTTTTAGTGGTGCGCACGGCATCTTG

H121A-Reverse

CAAGATGCCGTGCGCACCACTAAAACG

Y56A-Forward

CGCTGGCTTCGCGGAAGCTGGCTCTG

Y56A-Reverse

CAGAGCCAGCTTCCGCGAAGCCAGCG
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HmuUV HmuT

HtaB

HtaA

ChtB ChtA

ChtC

Figure 2.1 Schematic of hmu and cht heme uptake proteins of C. diphtheriae. ChtA/C
depicts each ChtA or ChtC which exhibit significantly high amino acid identity (11).
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A

Y223

S152

Y223
S52
M220
M220

Y56

Y56
H121
H121

B

F271
Y129

Y272
F271
Y129
H279
Y178

S125

Y272
S125

H279

Y178

Figure 2.2 I-TASSER homology model (2) of A: ChtB and B: ChtA using the
crystal structure of HtaB from C. glutamicum (4) as a template and displayed
using UCSF Chimera (13). Shown are location of, ChtB; S52, Y56 (axial
ligand), H121, M220, and Y223: ChtA; S125, Y129 (axial ligand), Y178, F271,
H279, and Y272.
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Figure 2.3 UV-visible spectra of ChtA (orange solid line), HtaA-CR2 (dashed red
line), ChtB (blue dashed-dotted line), and HtaB (green dotted line). Spectra were
taken in 100 mM Tris-HCl, 150 mM NaCl, pH 8.0 and are normalized to 1.0 at the
Soret.
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Figure 2.4 The UV-visible absorption of as-isolated ferric HtaB (solid line), Y56A
(dashed line), and H121A (dotted line). Spectra were taken in 100 mM Tris-HCl,
150 mM NaCl, pH 8.0 and are normalized to 1.0 at the Soret.
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Figure 2.5 Ferric high frequency rR of HtaB as a function of pH. Glycine (pH 9.6, black),
Tris-HCl (pH 8.8, red and 8.0, blue), and phosphate (pH 5.8, green) buffers at 100 mM were
used. Resonance Raman scattering was excited with 413.1 nm emission from a Kr+ laser
using 10 mW of power. The assignments are made by analogy with other heme proteins and
on the basis of depolarization ratios evident from Figure 2.27.
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Figure 2.6 Ferric high frequency rR of ChtB as a function of pH. Tris-HCl (pH 8.8, blue
and 8.0, red) and phosphate (pH 5.8, green) buffers at 100 mM were used. The excitation
wavelength from 413.1 nm from Kr ion laser with 11.4 mW of power. The assignments were
made based on polarization data in Figure 2.28 and by analogy with other heme proteins.
The nC=C band shifts under the n10 band as the pH is decreased indicating a change in the
interactions between the vinyl groups and the heme pocket.

53

Figure 2.7 Low-frequency spectra of ferrous HtaB excited with 413.1 nm (10 mW, black,
bottom, Kr+) and 441.6 nm (1.6 mW, red, top, HeCd). Both spectra have been normalized to
the ν7 band which lies outside the shown window. The resonance enhancement pattern with
441.6-nm excitation supports assignment of the 217-cm−1 band to the νFe−His mode, leading to
the conclusion that part of the heme is bound to the protein through a Fe−His bond (97).
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Figure 2.8 Backbonding correlation plot, relating νFe−CO and νC−O frequencies for groups of
proteins having the same trans (proximal) ligand. The two forms of HtaB−CO are shown as
filled red stars, while the two forms of ChtB−CO are filled green stars. HmuT and its
mutants, unfilled blue stars (63, 77); catalase, blue hexagon (112); and SmHasA(WT),
SmHasA(H83A), SmHasA(H32A), magenta ○ (93). The data for HRP, ▲ and globins, ■
have been compiled previously (93). The dotted line is the least squares fit for six-coordinate
heme carbonyls in which the proximal ligand is neutral imidazole from a His residue (93,
102, 103) (and references therein). The solid blue line represents a compilation of heme
proteins in which the ligand trans to CO is coordinated through an O atom that is hydrogen
bonded to an Arg (two hydrogen bonds) (77, 112). The solid magenta line is the least squares
fit for six-coordinate Fe−CO adducts which are coordinated through an O atom having a
single hydrogen bond to His or Tyr (93).
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Figure 2.9 Absorbance versus wavelength of a solution of heme-loaded HtaB
before and after incubation with heme-loaded ChtB. B: Absorbance versus
wavelength of a solution of heme-loaded ChtB before and after incubation with asisolated HtaB. The protein solutions were prepared in 100 mM Tris-HCl, 150 mM
NaCl pH 8.0.
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Table 2.2 Comparison of rR core-size marker bands (cm-1) of select ferric hemin proteins.

n4

n3
n3
6cHS 5cHS

His

1373

1483

Catalase

Tyr

1373

CdHmuT

Tyr/His

1371

CdHtaA

Tyr

1372

CdHtaB

Tyr/His

1370

1483

1520

1561

This paper

CdChtB

Tyr/His

1370

1486

1522

1560

This paper

CdChtA

Tyr

1373

1491

SdSHUT

Tyr

1369

1484

SmHasA

Tyr/His

1372

1476

YpHasA

Tyr

1369

1480

CcmE

Tyr

1373

Protein

Ligand(s)

Mb

n3
6cLS

1487
1475
1490

1511

1563

1514

n2
5cHS

1556

1522

(113)
1580

1568

1520

Reference

(7)

1569

1517

n2
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1570

1530

1503

1492

n2
6cHS

1522
1502

1487

n38

(1)

1589

1565
1561

(76)

This paper
(95)

1580
1567

(104)
(92)

1579

(114)
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2.6

Supplementary information
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CdChtA
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CgHtaA-CR2
CdHtaA-CR2
CgHtaB
CgHtaA-CR1
CdHtaA-CR1

TG-KECAITVESGTVKWGIKQSWRSYILGN-IAHGT---WKTSGHVKDNNREKSGNDFQF
ASQCEMVQVIESGTLKWGVKHSYRQYILNNKLANGN---WKVAGDIKEV-GEKRGKDFYF
DPANAADAKSTGEALTWGVRSSFNNYSGGP-TE-------------MLDGAKQNGTKNRF
KP----VTIATSGKLNWGIRESFNNYTNGA-SK-------------VEDGATLI-STNNF
-----MSLGVTQASAQWGVKASFQNYIRGS-IANGS---WTLNGVGFDNQQF-------PQCDASSRGVTQAHAAWGLKKSFQSYITGS-IAKGQ---WNLDGVGYSNGEF----------MKCRVVTTTGTADWSVRESFNNYLEGP-IANGAAYKYH-GGIEVRDGVETTGTKSAR
--MQTEYRTASDGSLNWGFRQSFRNYIQTG-VAKGS--------ITLGDGAS--DNGGNF
STAPAQAADSNQCSFNWGIRQSYRHYILKG-AAGKTGGQWATQGIGFSGDKT--GIDGAF
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TFS-GASGAVDPQAKSGFVK-----------FGGTMRFSGHHG-------------ILDL
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TIKDPKIVISNEENYVEAVVDSKQYPSGEWYKSNGP---VKIANLY--PGSATVDSKDNS
QIANIEISFNGNSGELIADVVSSDMDGNSTN--YGRTVVGT---LNFSALNVSATEA--NISNPEIVFNGATGTLFAQVRSSDMEGKKSD--YGRVAIGN---LTFSSLNASETAA--DFSNPTVKFDGNEGTLLVDFKSREFVD--TK-TVADFLTGTQAELATITFDEPIDLTQEN
TMSDIKMVFNGSSAQLVVDLVAREFKGTTYD-DIGEYIISDDIVLADVSLNSAADFSQDS
TFSDWKVVTHGSTADILVDYVSYDSDMSNTK-DRGPKITGDDVVLATINLNTPADPASGS
: . :

190
181
250
174
130
202
156
146
177

CdChtB
CdHtaB
CdChtA
CdChtC
CgHtaA-CR2
CdHtaA-CR2
CgHtaB
CgHtaA-CR1
CdHtaA-CR1

VSEWKTSGEDGAKLTLKGSNLQYTPQRGTDGHRGTIEGVDLLFMGQYDANYKPSVDDVEV
TAGWTLNETD---ATLSGSNMRYVPQPKTK--DNVIDGVDVIFMGQYDGDYNSDLDDVKV
-VTWSEIPA---LLTK--------------------DGAE-MFSNFYPVNS--GLDSLTF
-TEWTNVVSA--LANP--------------------GGVK-MFSEFYGENE--GLAPLSF
--S--GSASV--SLSQ--------------------SGSQ-AFADFYTPGT--QLDPISF
--S--GKATM--TLHP--------------------DGAG-AFAGFYEAGS--DLDPITF
-VT--VTGQT--KLTA--------------------TGVD-VMGTFYPEGE--ALAPITL
-ID--LSGTT--DLTA--------------------AGAQ-AFGGFYETGE--ALDPTGG
-ID--LSGST--TLSP--------------------EGAK-LFIA-YDVGS--PLDPTSG
*
:
* .
:

250
236
283
208
161
233
188
178
208

Figure 2.10 Clustal Omega alignment of CR domains for HtaA-CR1, HtaA-CR2,
HtaB, ChtB, ChtA, and ChtC from C. diphtheriae; HtaA-CR1, HtaA-CR2, and HtaB
from C. glutamicum (4).
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Figure 2.11 UV-visible spectra of as-isolated HtaB (dotted line), titrated with hemin
(solid line), and reconstituted on a Strep-tag column with hemin from metHb
(dashed line). Spectra were taken in 100 mM Tris-HCl, 150 mM NaCl, pH 8.0 and
are normalized to 1.0 at the Soret.
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Figure 2.12 UV-visible spectra of as-isolated HtaB H121A (dashed line) and
titrated with hemin (solid line). Spectra were taken in 100 mM Tris-HCl, 150
mM NaCl, pH 8.0 and are normalized to 1.0 at the Soret.
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Figure 2.13 UV-visible spectra of as-isolated HtaB Y56A (dotted line), titrated with hemin
(solid line), and reconstituted on a Strep-tag column with hemin from metHb (dashed
line). Spectra were taken in 100 mM Tris-HCl, 150 mM NaCl, pH 8.0 and are normalized
to 1.0 at the Soret.
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Figure 2.14 UV-visible spectra of as-isolated ChtB (dashed line) and reconstituted
on a Strep-tag column with hemin from metHb (solid line). Spectra were taken in 100
mM Tris-HCl, 150 mM NaCl, pH 8.0 and are normalized to 1.0 at the Soret.
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Figure 2.15 UV-visible spectra of heme-loaded ChtA before and passing through a
Sephadex G25 superfine column. Dotted: before treatment. Dashed/dotted line: One pass.
Dashed line: Two passes. Solid line: Three passes. Spectra were taken in 100 mM TrisHCl, 150 mM NaCl, pH 8.0 and are normalized to 1.0 at the Soret.
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Figure 2.16 Low frequency rR spectra of WT ChtB as a function of pH. Tris-HCl (pH 8.8,
blue and 8.0, red) and phosphate (pH 5.8, green) buffers were used at 100 mM. Raman
scattering was excited with 413.1-nm emission from a Kr+ laser, 11.4 mW. The band
assignments were made based on depolarization ratios (data not shown) and by analogy to
other heme proteins. Changes in relative intensities of bands attributable to propionate and
vinyl bending suggest that the heme-protein interactions near the heme edge are sensitive to
pH. Changes in relative intensities and frequencies of bands near 740 and 760 cm−1 are
suggestive of a pH-dependent change in deviation of the porphin core from planarity.
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Figure 2.17 Ferrous high frequency rR spectra of pH 8.8 HtaB as excited with 413.1 nm Kr+
laser with 4.8 mW power. Parallel polarized (black) and perpendicular polarized (red) spectra
allow for the identification of totally symmetric and non-totally symmetric core size marker
bands. Inset shows the UV-visible spectrum of ferrous HtaB.
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Figure 2.18 High-frequency rR spectra of ferrous ChtB at pH 8.8, excited with 413.1-nm
emission from a Kr+ laser with power of 10.2 mW. Parallel polarized (black) and
perpendicular polarized (red) spectra allow for the identification of the totally
symmetric and non-totally symmetric core size marker bands. Inset shows the UVvisible spectrum of ferrous ChtB.
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Figure 2.19 Resonance Raman spectra of the heme carbonyls of HtaB-WT. Raman scattering
was excited using 413.1-nm emission from a Kr+ laser; 5.7 mW. Natural-abundance
HtaB−CO (top), HtaB−13CO (middle) and 12CO−13CO difference (blue, bottom) spectra are
shown in the νFe−CO, δFeCO and νC−O regions. Bands in the low-frequency region were fit using
Gaussian peak functions (gray). These bands were used to calculate the red difference
spectrum superimposed on the blue points in the bottom left spectrum. The bands sensitive to
13
CO substitution are labeled with their respective mode designations. Spectra were recorded
at pH 8.8. Inset: UV-visible absorbance spectrum of HtaB.

67

Figure 2.20 Resonance Raman spectra of the ferrous carbonyls of WT ChtB
with conditions and interpretation as described in the legend of Figure 2.19.
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Figure 2.21 Electrospray ionization mass spectrometry detection of heme-bound
HtaB-WT (solid line), HtaB H121A (dashed line), and HtaB Y56A (dotted line) as a
function of collision energy voltage. The protein solutions were prepared in 20 mM
ammonium acetate, pH 6.8.
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Figure 2.22 UV-visible absorbance as a function of time for ChtA (orange-dashed
line); reaction was carried out in the presence of 4.0 M GdnHCl at 25 °C. HtaA-CR2
(red-solid line); reaction was carried out in the presence of 6.8 M GdnHCl at 37 °C. A
100 mM Tris-HCl, 150 mM NaCl, pH 8.0 buffer A was used for both experiments.
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Figure 2.23 UV-visible absorbance as a function of time for HtaB (green-dashed line)
and ChtB (blue-solid line); reactions were carried out in the presence of 4.0 M GdnHCl
at 25 °C in 100 mM Tris-HCl, 150 mM NaCl, pH 8.0.
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Figure 2.24 UV-visible absorbance as a function of temperature for ChtA. The
unfolding reaction was carried out in the presence of 1.5 M GdnHCl in 100 mM
Tris-HCl, 150 mM NaCl, pH 8.
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Figure 2.25 Fraction folded as a function of temperature for the of HtaB
(green-dashed line) and ChtB (blue-solid line). Experiments were
performed in 1 M GdnHCl in 50 mM NaH2PO4, pH 7.0.
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Figure 2.26 Fraction of folded protein as a function of temperature for HtaB (solid
line), H121A (dashed line), and Y56A (dotted line) mutants. The unfolding reaction was
carried out in the presence of 1.0 M GdnHCl in 50 mM NaH2PO4, pH 7.0.
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Figure 2.27 High frequency rR spectrum of ferric HtaB in 100 mM Tris pH 8.0 with
413.1-nm excitation from Kr+ laser with 10 mW of power. Parallel (black) and
perpendicular (red) polarized Raman scattering are shown to identify the totally
symmetric and non-totally symmetric core size marker bands (7).
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Figure 2.28 Polarized high-frequency rR spectra of WT ferric ChtB. Conditions as
described for Figure 2.27, except the laser power was 11.4 mW.
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3

CHARACTERIZATION OF C. DIPHTHERIAE CHTA AND PRELIMINARY
EXPERIMENTS
This chapter is additional work on C. diphtheriae ChtA, not reported in Chapter 2.

Expression, purification, UV-visible absorption spectroscopy, and thermal unfolding were
performed at Georgia State University.
3.1

General
UV-visible spectra were taken on a CaryBio UV-Visible spectrophotometer. Disposable

polystyrene cuvettes were used for Bradford assay studies and optical density measurements.
Water from a Barnstead water purifier had 18.2 mΩ resistance. Laemmli buffer was
commercially available. Protein samples containing SDS sample buffer were vortexed using a
VWR Mini Centrifuge C-1200. Mini-PROTEAN TGX Precast Gels from Bio-Rad were used to
run sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS PAGE). Lysogeny Broth
(LB) was prepared by using of 1 g of tryptone, 1 g of NaCl, and 0.5 g of yeast extract in 100 mL
of water and autoclaved for 45 min. After the LB media had reached room temperature,
kanamycin was added to a final concentration of 50 μg/mL. Terrific Broth (TB) was prepared
using 2.4 g of yeast extract, 1.2 g of tryptone, 0.23 g of K2HPO4, 1.64 g of KH2PO4, and 0.4 mL
of glycerol in 100 mL of water and autoclaved for 45 min. After the TB media had reached room
temperature, kanamycin was added to a final concentration of 50 μg/mL. UV-visible spectra
were taken on a CaryBio UV-visible spectrophotometer. Buffer A was 100 mM Tris-Cl and 150
mM NaCl at pH 8.0. Buffer B was 100 mM Tris-Cl, 150 mM NaCl, and 2.5 mM d-desthiobiotin
and 1.0 mM of EDTA at pH 8.0. Buffer C was a mixture of 70% Buffer A and 30% Buffer B.
ChtA concentrations were calculated from ε280 from ExPASY (25,485 M-1 cm-1). Hemin (Sigma-
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Aldrich) concentrations in dimethyl sulfoxide (DMSO) were calculated using ε624 = 6.23 mM-1
cm-1 (64). The Sephadex G25 medium and superfine grades were from GE Healthcare.
3.2

Materials and methods
3.2.1

Optimal growth and expression condition for ChtA

3.2.1.1 Comparison of TB and LB
An Erlenmeyer flask containing the E. coli strain BL21(DE3) carrying the chtA gene on
the [pET24a(+)] expression vector (a gift from Dr. Michael Schmitt) (8) was grown in 100 mL
Terrific Broth (TB) containing kanamycin (50 µg mL-1) was prepared with and without 0.3%
glucose. A 1 mL sample was preserved at room temperature. The remaining inoculum was
shaken at 20 °C/220 rpm for 20 h. A second sample of the inoculum was taken. The same
experiment was repeated with LB.
3.2.1.2 Post-induction temperatures and isopropyl-ß-D-thiogalactopyranoside concentration
The cells were grown in 100 mL Terrific Broth (TB) containing kanamycin (50 µg mL-1)
at 37 °C/220 rpm for 20 h. The culture was inoculated (100 µL each) into four separate Falcon
tubes each containing 10 mL TB with kanamycin and incubated under the same conditions until
an OD600 of 0.6 was reached. Two equal volumes (3 mL) from each culture were transferred to
eight additional Falcon tubes. Four of these tubes were induced by adding volumes of 15 and 30
µL of isopropyl-ß-D-thiogalactopyranoside (IPTG) to a final concentration of 0.5 and 1.0 mM,
respectively. The other four tubes were not induced. The inocula were allowed to express in
pairs, each with a pre- and post-induction culture for 3.5 h at 37 °C/220 rpm. The optical density
of the pre- and post-expression was used to determine the colony counts per volume of the liquid
culture:
𝑂𝐷!** ∗ 𝑥 = 1.0
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where 𝑂𝐷!** is the optical density of the expressed culture measured at a wavelength of 600 nm
and x is the cell volume. Table 3.1 gives an example of these calculations for 𝑂𝐷!** values of
1.19, 1.21, 1.29, 1.31, 1.46, and 1.44. The calculated volumes were harvested by centrifugation
at 7000 rpm/4 °C for 40 min. The pellets were collected and stored in a 20 °C freezer for 20 h.
The cell pellets were re-suspended in 75 µL of 1:19 of SDS sample buffer [(2-mercaptoethanol
(50 µL): Laemmli (950 µL)] and boiled at 90 °C for 10 min.
3.2.1.3 Optimal Density at OD600 and isopropyl-ß-D-thiogalactopyranoside concentration
E. coli strain BL21(DE3) carrying chtA gene on the [pET24a(+)] expression vector was
grown in 200 mL Terrific Broth (TB) containing kanamycin (50 µg mL-1) at 37 °C/220 rpm for
20 h. The culture (150 µL) was then inoculated into three separate Falcon tubes each containing
15 mL TB with kanamycin and incubated under the same conditions until the OD600 reached
0.57, 0.86, and 1.15. Two equal volumes (3 mL) from each culture were transferred to new six
Falcon tubes and induced by adding volumes of 9 and 15 µL of IPTG to a final concentration of
0.3 and 0.5 mM. The induced cultures were allowed to express for additional 4 h at 37 °C /220
rpm. The optical density of the post-expressed culture was used to determine the colony counts
per volume of the liquid culture as described above and harvested by centrifugation at 7000
rpm/4 °C for 40 min. The pellets were collected and stored in a 20 °C freezer for 20 h.
3.2.1.4 SDS PAGE
SDS sample buffer was prepared by adding 50 µL of 2-mercaptoethanol into 950 µL of
Laemmli buffer. The cell pellets were re-suspended in 75 µL of 1:19 SDS sample buffer,
vortexed and boiled at 90 °C for 10 min. The hot protein samples (4 µL), the protein ladder
(4 µL) and myoglobin (10 µL) were loaded into the wells using a pipette. The samples were run
through the stacking gel at 70 V for 15 min. The voltage was increased to 118 V and ran for an
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additional 45 min. The gel was washed with water and stained in Coomassie Brilliant Blue R250 for 1 h on an orbital shaker. The staining solution was recycled. To remove the stain, the gel
was incubated in 20% methanol and 10% acetic acid (destaining solution) for 16 h on an orbital
shaker. The destaining solution was recycled by filtering through an activated carbon filter. The
gel was washed with water twice and left to dry.
3.2.2

Titration of ChtA with hemin in DMSO

ChtA as-isolated (22.6 µM, essentially entirely in the apo form) was used for a twocuvette hemin titration in buffer A. Aliquots of a solution of 10.1 mM hemin in DMSO were
added sequentially to one cuvette containing the protein and a second cuvette, which served as a
blank, with buffer A only. The sample was allowed to stand for 30 min after each addition. The
volume of DMSO in solution did not exceed 0.2%. UV-visible spectra were recorded after each
hemin addition up to a hemin:protein ratio of 0.90. At the end of the titration, the sample was
passed through a Sephadex G25 medium column.
3.2.3

Reconstitution of ChtA with hemin in DMSO

Hemin in DMSO (1.89 mM, 2.30 µL) was added to a solution of ChtA (1400 µL, 34.6
µM) in buffer A. The hemin:protein ratio was 0.90. The solution was allowed to incubate for 30
min. Spectra were taken with baselines of buffer only and buffer with an equivalent amount of
hemin. The sample was passed down a Sephadex G25 superfine column twice. The experiment
was repeated with a sample of ChtA (28.1 µM) that was initially more heme loaded (Soret:280
nm ratio of 0.29). Addition of one equivalent of hemin in DMSO gave a sample that was passed
down a Sephadex G25 superfine column three times.
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3.2.4

ChtA hemin in potassium hydroxide sequential reconstitution

ChtA as-isolated (12.2 µM, essentially entirely in the apo form) was used for a twocuvette heme titration in buffer A. A 115 µM solution of hemin in 100 mM KOH was diluted
1:50 with 100 mM NaH2PO4, pH 7.5. Two 20 µL aliquots were added sequentially to both the
cuvette containing the protein and a cuvette with buffer A only. The samples were allowed to
stand for 30 min after each addition. UV-visible spectra were recorded after each hemin addition
(hemin:protein ratios of 0.21 and 0.42). At the end of the titration, the sample was passed
through a Sephadex G25 superfine column.
3.2.5

Concentration measurement: Bradford assay for ChtA

A stock solution of bovine serum albumin (BSA) (6.2 μM, ε280 = 43824 M-1 cm-1, Fischer
Scientific) was dissolved in H2O and used as a standard for the Bradford assay. The standard
solutions were prepared by adding aliquots of 2, 4, 6, and 8 μL of BSA into disposable cuvettes
with 798, 796, 794, and 792 μL of buffer A, respectively. Coomassie Blue aliquots (200 μL) of
the Bio-Rad were added at 5 min intervals into cuvettes and allowed to sit for 10 min at room
temp before the UV-visible spectra were recorded. A similar procedure was used for ChtA (18.2
μM, 4 μL). The absorbance at 595 nm was used with the calibration curve from the Bradford
assay to determine the stock concentration of ChtA.
3.2.6

Extinction coefficient measurement: Pyridine hemochrome assay of ChtA

The ChtA solution (18.2 μM, 500 µL) used for Bradford Assay was transferred into a
capped black quartz cuvette with an equal volume of pyridine solution (4.0 mL pyridine, 6 mL of
400 mM NaOH). A saturated sodium dithionate solution was prepared in water in a capped glass
vial; 10 μL of this solution was added to the cuvette containing ChtA and the pyridine
hemochrome solution using a glass syringe. The solution mixture was quickly mixed using a
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1000-µL glass syringe and UV-visible spectrum was immediately recorded with a baseline of
pyridine solution only.
The extinction coefficient for ChtA at Soret was calculated by using Beer’s law from the
absorbance value at Soret and molar concentration of heme. The holo-ChtA concentration was
determined using this extinction coefficient. The heme loading was estimated by comparing the
holo-ChtA with the total (holo-ChtA and apo-ChtA) protein concentration that was determined
using Bradford assay described above.
3.2.7

Investigation of protein secondary structure: Circular dichroism

Circular dichroism (CD) spectra of BSA, Mb, and ChtA were recorded using Jasco J1500 CD spectropolarimeter and a quartz cuvette having a 1.0 cm path length. A 1.5 and 5.0 µM
samples of myoglobin and ChtA, respectively, were recorded in each of 10 mM KH2PO4 and
buffer A at pH 7.0. Except for BSA, four (0.75, 1.5, 3.0, and 5 µM) different concentrations were
used in 10 mM KH2PO4. The final spectra represent an average of 20 scans.
3.3

Results and discussion
3.3.1

Optimal growth and expression condition for ChtA

The goal of this work was to determine optimal growth and expression conditions for
ChtA. There are many factors that can influence protein yields and quality during expression, but
this study focused on the comparison of growth medium, carbon sources, temperature, inducer
concentrations, and induction conditions. These parameters were tested by involving varying
levels of each parameter over a certain range, while holding the other test variables constant.
Our work involved a ChtA construct with an N-terminal Strep-tag® (Figure 3.1)(8). The
first step was selecting a medium that would promote the growth of cells. The cell population
levels were compared between Lysogeny Broth (LB) and Terrific Broth (TB) with and without
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0.3% glucose. There was no growth observed in LB with or without 0.3% glucose after 20 h
(Figure 3.2), as determined by the lack absorbance of at 600 nm and no cells settled at the bottom
of the cuvette. A higher cell population was observed for TB (Figure 3.2). The OD600 for the
samples with and without glucose with both approximately 2.8, indicating that glucose is not
necessary with TB.
In the second set of experiments, the relative levels of expression were analyzed using the
two sets of temperatures (20 and 37 °C) and final IPTG concentrations of 0.5 and 1.0 mM. The
temperature seemed to make little difference as seen in the overall intensity of the ChtA bands
(Figure 3.3). However, 37 °C conditions seemed to give purer protein and this temperature was
used going forward. The two final IPTG concentrations (0.5 and 1.0 mM) gave similar
expressions. However, for this study holo-ChtA is preferred. To allow for the possibility of heme
biosynthesis to “catch-up” with ChtA synthesis, a final IPTG concentration of 0.5 mM was
chosen.
The third set of experiments were run to choose the best induction point in terms of cell
growth. The cultures were induced at OD600 values of 0.57, 0.86, and 1.15 with final IPTG
concentrations of 0.3 mM and 0.5 mM for each. ChtA expression levels for final IPTG
concentrations of 0.3 and 0.5 mM were similar (Figure 3.4). Samples induced at OD600 values of
0.57 and 0.86 (very similar results) expressed more ChtA than that at 1.15.
The final growth conditions chosen for ChtA were the temperature of 37 °C, an induction
OD600 between 0.6 and 0.9 and a final IPTG concentration of 0.3 mM.
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3.3.2

Homology modeling

Homology models of HtaB, ChtB, ChtA, and HtaA-CR2 from the I-TASSER prediction
program were based on the recent structures from C. glutamicum (4). The important residues
around the heme for the ChtA and ChtB models are described in the manuscript.
The HtaA-CR2 key residues are positioned similarly to those in the ChtA model (figure
in Chapter 2 manuscript). In the HtaA-CR2 model, these residues include the axial ligand Y129
and a hydrogen-bond partner to H178 (Figure 3.5). S125 and Y272 both form hydrogen bonds
with one of the heme propionates. Phenylalanine residue F271 π-stacks with one of the pyrrole
units of the heme. H179 presumably assists in heme transfer.
The HtaB key residues are positioned similarly to those in the ChtB model (Figure in
Chapter 2 manuscript). The HtaB model has tyrosine Y56 as the axial ligand; this residue also
forms a hydrogen bond with H121 (Figure 3.5). S52 and Y223 both form a hydrogen bond with
one of the heme propionates. The canonical π-stacking phenylalanine residue (F271) present in
ChtA and HtaA-CR2 is not present in the HtaB model.
It is interesting to note that the two short α-helices located on opposite sides of the heme
hold key residues, as is also seen in NEAT domains (31-33). In both HtaA and NEAT SXXXXY
motifs, the serine forms a hydrogen bond with one of the heme propionates. The tyrosine, four
residues away from serine, π-stacks with one of the pyrrole units of the heme in NEAT domains
(45), whereas in the HtaA domains, this ligand is the axial ligand.
3.3.3

Hemin addition to ChtA

Reconstitution. As isolated, ChtA has very little hemin bound (Figure 3.6). Hemin in DMSO
was titrated into a ChtA solution to a hemin:protein ratio of 0.90 (Figure 3.6). The increase in the
Soret was a linear function of the amount of added hemin (Figure 3.7). Passage of a reconstituted
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sample down a Sephadex G25 superfine column gave a narrower Soret, indicating that some of
the red shoulder of this band was probably due to surface-bound hemin (Figure 3.8). Passage of
this sample through the column a second time did not result in a narrower band (data not shown).
A second reconstitution sample, starting with more hemin in the as-isolated ChtA, was passed
through a Sephadex G25 superfine column three times. The Soret was slightly narrower each
time (Figure in Chapter 2 manuscript). A plot of the spectra after one passage in the first
experiment and after three passages in the second experiment shows that they are essentially
identical, indicating that the FWHM of the Soret of holo ChtA is 67.5 nm (Table 3.2). Because
hemin seems to bind to the surface of the protein, it is helpful not to add more than one
equivalent of hemin to the protein in reconstitution efforts. It should be noted that passage
through a Sephadex G25 medium column removed less hemin than did the Sephadex G25
superfine column (Figure 3.9).
ChtA was also reconstituted with hemin in KOH/phosphate solution (Figure 3.10). This gave
broader Soret than the reconstitution with DMSO (Figure 3.11). Figure 3.12 shows the UVvisible spectra of hemin and the reconstituted sample before and after treatment with Sephadex
G25 superfine column. Even though Sephadex removes unbound hemin, the Soret is still broader
after reconstitution using a KOH solution compared to a DMSO solution of hemin (Figure 3.11).
The spectra of holo-ChtA are quite similar to other tyrosine-bound heme proteins in heme uptake
pathways (Table 3.2). The overlay (Figure in Chapter 2 manuscript) of ChtA with HtaA-CR2,
HtaB, and ChtB from C. diphtheriae shows that all have similar spectra. All of them have a Soret
at about 405 nm and three bands to the red, the β- and α-bands at about 509 and 546 nm,
respectively, and a charge-transfer band at about 626 nm.
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3.3.4

Determination of Soret heme loading and extinction coefficient

A ChtA (0.91 μM, 500 µL) solution, determined via Bradford assay, was used for the
pyridine hemochrome assay. The reduced bispyridine ferrous heme complex (upon mixing with
sodium dithionate), consists of signature β-peak at 525 nm and α-peak at 556 nm (87) as well as
a shift in Soret peak to 418 nm (113). Given the extinction coefficient of 34.53 mM-1 cm-1 at 556
nm (87) the concentration of pyridine hemochrome was 0.60 μM (which is also hemin
concentration in the original ChtA solution). Thus, the Bradford assay, in conjunction with the
pyridine hemochrome assay showed that heme reconstituted ChtA was 65% heme loaded.
Given that Soret:280 nm ratio was 1.6 for ChtA with 65% heme loading, a Soret:280 nm
ratio of 2.5 was calculated for fully heme-loaded ChtA.
The extinction coefficient of 1.4 x 105 M-1 cm-1 for ChtA at the Soret was calculated by
using Beer’s law with known absorbance (0.833) value at the Soret and corresponding molar
(0.60 μM) concentration.
3.3.5

Experimental aspects of circular dichroism (CD) spectroscopy

These studies aimed to determine the optimal conditions required for obtaining reliable
ChtA CD data specific to the instrument.
Sample concentration. In the first set of experiments, BSA was used as the model protein
to study the concentration effect on the CD data. To take an accurate CD reading, enough
photons must reach the detector. Figure 3.13 shows the CD spectra of BSA solutions at varied
concentrations. At BSA concentrations above 3 µM, the spectrum becomes distorted; at 5 µM, a
Gaussian shape spectrum shifted to lower energy wavelengths was observed. This effect has
been observed in another laboratory (114). The absorbance spectrum of 5 µM BSA has a
maximum signal at 207 nm, which is twenty-six times more than the signal at 225 nm (Figure
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3.13, inset). In the 5 µM BSA CD spectrum, not enough photons reach the detector at
wavelengths ranging from 194 and 213 nm. At the higher energy wavelengths range from 214
nm to 240 nm, the absorption signal decreased (Figure 3.13, inset), accompanied by a Gaussian
shape CD spectrum shifted to lower energy wavelengths (Figure 3.13). Even further to the red,
the absorption of the CD signal decreases because BSA does not absorb at those wavelengths.
To measure reliable CD signals specific to BSA enough photons at wavelengths between
205 and 215 nm must reach the detector (115). The two lower (0.75 and 1.5 µM) concentrations
gave CD signals (Figure 3.13) very similar to the literature. Hence the upper limit of BSA
concentration necessary for a reliable signal for CD instrument used is ~ 2.0 µM.
Buffer conditions. In the second set of experiments, Mb was used as a model protein to
study the effect of salt on the CD spectra. Figure 3.14 shows the spectra of Mb in buffers A and
10 mM potassium phosphate. The Mb spectrum in potassium phosphate buffer compares very
well with the literature (116). A similar phenomenon to that described above was also observed
for the Mb in buffer A, indicating that at a higher salt concentration, not enough photons reach
the detector; the spectrum shifts from 200 nm to 208 nm compared to that of Mb in potassium
phosphate.
ChtA loses its heme under low salt conditions, as shown by the spectra (Figure 3.15) after
dialysis from buffer A into 10 mM ammonium acetate. It was necessary to record the spectra
under fairly high salt conditions, e.g., buffer A; this resulted in a slight red shift for the spectrum,
as was observed for Mb (Figure 3.14).
The overlay CD spectra (Figure 3.16) of ChtA with HtaA-CR2, HtaB, and ChtB from C.
diphtheriae are similar. All the proteins are largely β-sheets, as indicated by a single local
minimum at approximately 215 nm.
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Table 3.1 IPTG concentrations, post-expression OD600, and volume of liquid culture.
IPTG

Post-expression

Culture volume

mM

OD600

µl

0.50

1.19

840

0.30

1.21

829

0.50

1.29

777

0.30

1.31

766

0.50

1.46

686

0.30

1.44

693
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Table 3.2 Tyrosine-bound heme proteins in heme uptake pathways.
Protein

Ligand

FWHM

Q Bands (nm)

(nm)

Soret
(nm)

β

α

Charge
transfer

References

S. aureus IsdA-N

Tyr

66.7

403

497

535

625

(55)

S. aureus IsdB-N2

Tyr

60.6

405

504

538

630

(119)

S. aureus IsdC-N

Tyr

65.0

402

503

536

627

(49)

S. aureus IsdH-N3

Tyr

72.7

401

498

535

630

(119)

C. diphtheriae
HtaA-CR2

Tyr

65.0

406

508

546

626

(1)

C. diphtheriae HtaB

Tyr

37.5

408

504

542

625

Chapter 2

C. diphtheriae ChtB

Tyr

50.0

407

501

542

625

Chapter 2

C. diphtheriae
ChtA

Tyr

67.5

405

509

542

628

This work

Y. pseudotuberclosis
HasA

Tyr

60.0

402

500

535

620

(92)

P. aeruginosa HTP

Tyr

76.4

400

500

534

624

(120)

S. dysenteriae ShuT

Tyr

60.9

400

500

521

617

(95)
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>ChtA-CR-29.4 kDa
MASWSHPQFEKGAEHVVEDAANDSAIVTTDNDQGSAVSEEATADDVVTDGKND
PKGLAETVKEIEDVSDKAITAGEKAVSLKDAEDRDPANAADAKSTGEALTWGVR
SSFNNYSGGPTEMLDGKQNGTKNRFTFQLESVTDYEATEKLEAKFKGGVHYQK
YCADEASHSDCQLDLKIENPRIVIAKGGSHVFAKVSSKKYQSSGTYNDGEDDARP
IAQLYTANATFKEEDCKVTWSEIPALLTKDGAEMFSNFYPVNSGLDSLTFSDKS

Figure 3.1 ChtA sequence with a (WSHPQFEK) N-terminal Strep-tag. Conserved
tyrosines; Y129 (Y1), Y178 (Y2), and Y272 (Y3) are shown in red (8).
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glucose

no glucose

glucose

no glucose

Figure 3.2 B2:Visual comparison of the cell growth with and without 0.3% glucose in LB
after 20 h, B2 :Visual comparison of cell growth with and without 0.3% glucose after 20 h.
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37 °C
0.5

0.0

1

2

1.0
3

20 °C
0.0
4

0.5

0.0 IPTGmM
5

6

~29.4 kDa

Figure 3.3 Expression of ChtA induced (OD600, 0.60) by addition of 0.50 mM (lanes 1 and 5),
1.0 mM (lane 3) IPTG at 37 °C for 3.5 h (lanes 1-4) and 20 °C for 20 h (lanes 5 and 6). Lanes
2, 4, and 6 are without IPTG.
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0.57
0.50
1

0.30
2

0.86
0.50
3

1.15
0.30
4

0.50
5

OD600
0.30

IPTG mM

6

~29.4 kDa
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Figure 3.6 UV-visible spectra for two-cuvette hemin titration of ChtA (22.6 µM) up
to a hemin:protein of 0.90. All spectra were taken in buffer A, pH 8.0.
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Figure 3.8 UV-visible spectra of heme-loaded ChtA before and after treatment with
Sephadex G25 superfine column. Dashed line: Two passes after hemin reconstitution of
ChtA (34.6 µM) up to a hemin:protein of 0.90. Solid line: Three passes after hemin
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Figure 3.10 UV-visible spectra for two-cuvette hemin titration of 12.1 µM ChtA
with 2.54 µM and 4.85 µM hemin. Hemin used to perform titration was in 100
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99

1.0

DMSO
KOH

Absorbance

0.8

0.6

0.4

0.2

0.0
250

350

450

550

650

750

Wavelength (nm)
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4

APPROACHES TO REACTION OF DECHLOROMONAS AROMATICA CHLORITE
DISMUTASE WITH NITRITE
Dechloromonas aromatica is a β-proteobacterium that uses the per(chlorate) reduction

pathway to catalyze the formation of dioxygen, deriving energy from this process (117). ClO4- is
reduced to chlorate (ClO3-), and ClO3- to ClO2- via perchlorate reductase (PerR). Chloride
dismutases (Clds) then detoxify chlorite (ClO2-) to chloride (Cl-) and dioxygen (O2) (118, 119).
Clds have also been identified in some nitrite-oxidizing bacteria, such as in Nitrobacter
winogradskyi (120). This microorganism gains energy from oxidation of NO2- to NO3- via nitrite
oxidoreductase (Nxr). The presence of the Cld-like protein in the nitrite-oxidizing enzymes
suggests a close relationship between per(chlorate) and nitrite reduction pathways (121).
Perchlorate (ClO4-), chlorate (ClO3-), chlorite (ClO2-), and nitrite (NO2-) are
environmental pollutants (85). Increasing concentration levels of these contaminants have been
identified in soil, drinking water, and groundwater. Because chlorate sources often have
associated nitrite (122), it is important to study the reaction of Clds with NO2- as well as ClO2-.
The goal of this work is to identify the products of the reaction of NO2- with D. aromatica
chlorite dismutase (DaCld). Our experiments to begin this research included growth and
expression optimization of DaCld.
The sections below give a review of the production of ClO2-, ClO3-, ClO4-, and NO2- in
the environment, followed by the biochemistry of DaCld.
4.1

Presence of oxyanion in the environment and analysis
4.1.1

Perchlorate

In the United States, perchlorate (ClO4-) is manufactured for use in rockets, missiles, and
fireworks. ClO4- also occurs in the environment, mostly in arid areas by the oxidation of volatile
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atmospheric chlorine (123). Much of the knowledge on ClO4- effects on human health came from
clinical studies on the use of potassium perchlorate to treat hyperthyroidism in the 1950-60s
(124). In the 1950s, gastrointestinal irritation, skin rash, and lymphadenopathy were reported
after treatment of hyperthyroidism with KClO4- at doses of 400 mg per day. In the 1960s,
aplastic anemia and agranulocytosis were reported for patients treated with 400 to 1000 mg ClO4per day for up to 33 weeks. These treatments were discontinued in the United States in the mid1960s.
The toxicological impact has become a growing interest due to the persistent presence of ClO4in drinking water (125, 126). ClO4- competes with the sodium and iodide symporter (NIS); when
ingested, the compound is transported to the thyroid and interferes with the iodide uptake.
Jackson and colleagues have reported that 89% of U.S adults are either directly or indirectly
exposed to ClO4- from tap water (127). The average concentration of ClO4- reported was 4 µg L-1
in 160 drinking water supplies located in 26 states and two territories in the United States; 420
µg L-1 was found in a single surface water in Puerto Rico (128). As of May 2020, ClO4- is an
unregulated contaminant in the United States (129).
ClO4- not taken up with NIS is secreted in urine and milk unchanged (130, 131). A higher
concentration has been detected in breast milk (10.5 μg L−1) than in dairy milk (2.0 μg L−1)
(132).
4.1.2

Chlorate and chlorite

Chlorate (ClO3-) and chlorite (ClO2-) are environmental pollutants (133). These
disinfection by-products (DBPs) result from the decomposition of chlorine dioxide (ClO2),
commonly used in the purification of water. Chlorite, the predominant species (63%), is
regulated in the United States; concentrations of up to 1.0 mg L−1 in drinking water are allowed
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(133, 134). ClO3- and ClO2- are also by-products of commercial bleach. ClO2-, ClO3-, and ClO2
are also used in food processing as decolorizing agents and as additives in paper and products
used for food packaging; as a result, ClO2- has been detected in some foods such as flour (134).
Early studies showed that exposure to an acute dosage of the DBPs was associated with
decreases in brain mass, changes in thyroid functions, and induced hematological responses in
animals (134). In one instance, ingestion of 28% per 100 mL volume of sodium chlorite resulted
in methemoglobinemia, hemolysis, and acute renal failure (135).
4.1.3

Nitrite

Nitrite (NO2-) can be readily obtained by the reduction of nitrate (NO3-) (136). These
compounds are commonly used as food preservatives and fertilizers. Concentrations up to 49 mg
L−1 of nitrite detected in farm soil has been attributed to nitrogen fertilizers (122). The occurrence
of nitrite in drinking water and groundwater is mainly via nitrate leaching from the soil. In the
United States, the maximum contaminant level of NO2- allowed in drinking water is 1.0 mg L-1
(137). At higher concentrations, the contaminant leads to irreversible conversion of hemoglobin
to methemoglobin (138). Potential health effects from long-term exposure of NO2- on infants
below the age of six months include shortness of breath and blue-baby syndrome (137).
The incorporation of NO2- into food chains is commonly through meat and fish products
(122). A concentration of up to 99 mg L−1 has been detected in farmed fish tissues. In meat
products, NO2- is used to inhibit bacterial growth and maintain fresh-pink-meat color (139, 140).
The NO2- concentration required to inhibit microbial growth in meat products is approximately
42000 mg L-1 (141). As of 2019, the maximum permissible concentration NO2- in finished meat
products was 200 mg L-1 (142).
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In general, NO3- occurs with NO2-. NO3- is an important plant nutrient, particularly in
leafy and some root vegetables (143). Average concentrations of NO3- in these sources range
from 175 to 1220 mg per serving.
Ingested NO3- is absorbed in the small intestine; 25% is excreted in the mouth, where oral
bacteria reduce it to NO2- (144). The role of dietary NO2- and NO3- are of interest, as they are
precursors of N-nitroso compounds (NOCs), which induce pancreatic tumors.
Under physiological conditions, NO2- and NO3- can be recycled in the blood to form nitric
oxide (NO) (145). Collectively, the reduction regulates blood flow and tissue responses under
hypoxic conditions. Lower concentrations (1.2 nM g-1) of NO2- assist in protecting vascular
tissues against ischemic damage (146) e.g., during reperfusion injury following pulmonary
hypertension and organ transplant. The beneficial effect of NO2- seems to be mediated by the
release of NO under hypoxia. Higher concentrations of NO may cause DNA damage and
promote carcinogenesis (147).
4.1.4

Biochemistry of Dechloromonas aromatica chlorite dismutase (DaCld)

DaCld is a homo-pentameric protein; each subunit has a heme pocket consisting of 11
residues (Figure 4.1) (6). The heme has residues RLTF on one side and YQWWHEH on the
other. The X-ray structure complex with NO2- (PDB 3Q08) reveals that the substrate interacts
directly with the heme iron and the distal R183 residue. E220 forms a hydrogen bond with the
axial ligand H170 and one of the heme propionates, whereas the Y227 stacks with the heme
porphyrin ring.
The role of Arg183 in DaCld has been probed by replacing it with residues known to be
important in the other members of the Cld protein family (3, 6). Blanc et al. found that the
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catalytic efficiencies of the mutants were not completely lost but decreased in the order wildtype
> R183K >> R183Q >>> R183A.
4.1.5

Proposed mechanism reaction of chlorite decomposition

Proposed Cld mechanism involves two successive intermediates; one is via heterolytic
and the other, via homolytic bond cleavage (Figure 4.2).
The heterolytic bond cleavage: The first step involves the formation of the Fe(III)-ClO2complex, followed by heterolytic bond cleavage of ClO2-, generating the ferryl-porphyrin cation
radical, compound I [(Por•+)Fe(IV)=O] and a hypochlorite (ClO-) (148, 149). The subsequent
nucleophilic attack of ClO- at the ferryl-oxygen of compound I generates a Fe(III)-OClO-,
followed by elimination of O2 and Cl-.
The homolytic bond cleavage: The first step involves the formation the Fe(III)-ClO2complex, followed by a homolytic bond cleavage of ClO2-, generating the ferryl-porphyrin,
compound II [(Por)Fe(IV)=O] and a hypochloryl radical (ClO•) (148, 149). Recombination of
the radical allows for the release of O2 and Cl-.
UV-visible spectroscopy studies reveals that reaction intermediates, compound I and
compound II, exist as a mixture (119). As indicated by the isosbestic points at 355 nm and 440
nm, in addition to the Soret shift from 395 nm to 415 nm.
This work is in collaboration with Dr. Kenton Rodgers of North Dakota State University
who provided the DaCld plasmid.
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4.2

Materials and methods
4.2.1

Optimal growth and expression condition for Dechloromonas aromatica
chlorite dismutase

4.2.1.1 Comparison of TB and LB and isopropyl-ß-D-thiogalactopyranoside concentration
Two 200 mL flasks of Terrific Broth (TB) containing kanamycin (50 µg mL-1) were
prepared, one with and the other without 0.3% glucose. Two volumes of 5 mL were transferred
from these solutions into two separate Falcon tubes. Each Falcon tube was inoculated with a
different colony containing the gene daCld in a pET41a(+) expression vector [previously
transformed into E. coli strain Rosetta(DE3) pLysS] and incubated at 37 °C/180 rpm for 18 h.
Four additional Falcon tubes were prepared, each with 25 mL TB, two with and two
without 0.3% glucose and inoculated with the cell culture (1 mL) from the previously incubated
for 18 h samples. One set of two tubes (with and without glucose) was inoculated with one (1
mL) of the 18 h samples and the second set of two tubes with the other. The inoculated samples
were left to grow at 37 °C/180 rpm until an OD600 of 0.6 was reached for one set of tubes and 0.9
for the other. Three 5 mL aliquots were transferred from each of these four Falcon tubes to three
new falcon tubes to give a total of twelve falcon tubes. Of the sets of three, one was not induced,
one was induced by adding a volume of 5 µL of isopropyl-ß-D-thiogalactopyranoside (IPTG) to
a final concentration of 0.1 mM and the third was induced by adding a volume of 15 µL of IPTG
to a final concentration of 0.3 mM.
The sets of three were allowed to express for 3 h at 37 °C/180 rpm. The optical density of
each sample was used to estimate the colony counts per volume of the liquid culture:
𝑂𝐷!** ∗ 𝑥 = 1.0
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where 𝑂𝐷!** is the optical density of the pre- and post-expression culture measured at
a wavelength of 600 nm and x is the volume of liquid culture. The calculated volumes
(approximately equal cells) were transferred into twelve separate Eppendorf tubes and harvested
by centrifugation at 7500 rpm/4 °C for 45 min. The pellets were collected and stored at 20 °C for
20 h.
The same experiment was repeated for LB with and without 0.3% glucose. However, the
induced cultures were allowed to express for additional 18 h at 18°C /180 rpm.
4.2.1.2 Pre- and post-induction temperatures
Terrific Broth (TB) containing kanamycin (50 µg mL-1) was prepared with 0.3% glucose.
From this solution, 10 mL was transferred into a Falcon tube, and inoculated with one colony
containing the gene daCld in a pET41a(+) expression vector [previously transformed into E. coli
strain Rosetta(DE3) pLysS] and incubated at 37 °C/180 rpm for 18 h.
Two Erlenmeyer flasks were prepared, each with 494 mL TB with 0.3% glucose and
inoculated with the cell culture (2 mL) from the 18 h samples. The inoculated samples were left
to grow at 37 °C/180 rpm until an OD600 of 0.28 was reached for one flask and 0.75 for the other.
From each of these flasks, one 4 mL aliquot was transferred into a Falcon tube. These sets of two
tubes were not induced. The remaining samples (490 mL) each, were induced by adding volumes
of 490 µL IPTG to a final concentration of 0.1 mM. The inocula were allowed to express in
pairs, each with a pre- and post-induction culture for 15 h at 20 °C/180 rpm. To determine the
volumes necessary for equal amounts of proteins for SDS PAGE, the optical densities of the
pre- and post-expression inocula samples were used to as described in the formula above. The
calculated volumes were transferred into separate Eppendorf tubes and harvested by
centrifugation at 7500 rpm/4 °C for 45 min. The two large post-induction samples were
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harvested separately via centrifugation (JA-18 rotor, 8000g) at 4 °C for 45 min. The pellet from
each sample was washed by suspending in 20 mM Tris buffer pH 8.5 (2 mL buffer per gram of
cells) and centrifuging at 8500 rpm /4 °C for 45 min. The cell pellet from each was collected and
stored in a 20 °C freezer.
4.2.1.3 SDS PAGE
SDS sample buffer was prepared by adding 50 µL of 2-mercaptoethanol into 950 µL of
Laemmli buffer. The cell pellets were thawed at room temperature in a water bath and resuspended in 40 µL of 1:19 SDS sample buffer, vortexed and boiled at 90°C for 20 min. The hot
protein samples (5 µL), and a protein ladder (4 µL) were loaded into the wells using a pipette.
The samples were run through the stacking gel at 70 V for 15 min. The voltage was increased to
118 V and run for an additional 45 min. The gel was washed with water and stained in
Coomassie Brilliant Blue R-250 for 30 min on an orbital shaker. The staining solution was
recycled. To remove the stain, the gel was incubated in 20% methanol and 10% acetic acid
(destaining solution) for 16 h on an orbital shaker. The destaining solution was recycled by
filtering through an activated carbon filter. The gel was washed with water twice and left to dry.
4.3

Results and discussion
4.3.1

Optimal growth and expression condition for Dechloromonas aromatica
chlorite dismutase

The goal of this work was to determine optimal growth and expression conditions for a
(Dechloromonas aromatica chlorite dismutase) DaCld construct (Figure 4.3). There are many
factors that can influence protein yields and quality during expression, but this study focused on
the comparison of growth medium, carbon sources, temperature, optimal density at induction,
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and inducer concentrations. These parameters were tested by involving varying levels of each
parameter over a certain range, while holding the other test variables constant.
The first step involved selecting a medium that would promote the growth of cells. The
cell population levels were compared with Terrific Broth (TB) and Lysogeny Broth (LB) after
three and 18 h post-induction growth, respectively. A higher cell population was observed in TB
than in LB as indicated by larger OD600 values for TB compared to those of LB. This indicates
that a rich growth medium (TB) is preferred.
The second set of experiments looked at the effect of glucose. Glucose seemed to make
no difference in the cell population of cultures grown in TB as indicated by similar OD600 values
of approximately 1.33 at harvest. For LB, a higher cell population was observed with glucose, as
indicated by OD600 values at harvest of 1.24 and 0.93 for LB with and without glucose,
respectively.
Looking at the levels of expression itself via SDS PAGE, cells grown in TB with glucose
expressed more DaCld than those grown in TB without glucose (Figure 4.4 and 4.5). No
expression was observed for LB without glucose as indicated by no presence of a protein band at
~28.1 kDa (Figure 4.6). DaCld expression was observed for LB with glucose (Figure 4.7) but
significantly less compared to TB with and without glucose (Figure 4.4 and 4.5). Overall, these
data indicate that a richer medium enhances the expression of DaCld.
The third set of experiments were run to choose the best induction point. The relative
levels of expression were analyzed for two sets of OD600 (0.6 and 0.9) both for TB with and
without glucose, and LB with and without glucose. There were no differences observed in
expression levels between these two sets of OD600 values for each of the media sets. Hence, any
induction OD600 between 0.6 and 0.9 was acceptable.
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In the fourth set experiments, the relative levels of expression were analyzed using the
two sets of final IPTG concentrations of 0.1 and 0.3 mM. The IPTG concentration seemed to
make little difference as seen in the overall intensity of the DaCld bands. However, 0.1 mM of
IPTG seemed to give purer protein (Figure 4.4). Additionally, for this study holo-DaCld is
necessary. To allow for the possibility of heme biosynthesis to “catch-up” with DaCld synthesis,
a lower IPTG concentration is preferred. In the end, a final IPTG concentration of 0.1 mM in TB
with 0.3% glucose was used.
In the fifth set of experiments, lower temperatures of growth and expression, 30 and 20
°C, respectively, were implemented in an effort to achieve heme-loaded DaCld (117). Heme
loading is indicated by pink and red color. The relative levels of expression were analyzed for
two sets of OD600 (0.28 and 0.75) using these lower temperatures. An induction OD600 of 0.28
resulted to a more colored cell pallet than that of 0.75 (Figure 4.8).
The final growth and expression conditions chosen for E. coli strain Rosetta(DE3),
growth and expression temperatures of 30 and 20 °C, respectively, an induction OD600 between
0.25 and 0.30 and a final IPTG concentration of 0.1 mM.
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Figure 4.1 Heme pocket of DaCld including a nitrite ligand bound to hemeiron and H-bonding with Arg 183 (6).
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Figure 4.2 Proposed Cld mechanism involves two successive intermediates (3).
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MQPMQSMKIERGTILTQPGVFGVFTMFKLRPDWNKVPVAERKGAAEEVKK
LIEKHKDNVLVDLYLTRGLETNSDFFFRINAYDLAKAQTFMREFRSTTVG
KNADVFETLVGVTKPLNYISKDKSPGLNAGLSSATYSGPAPRYVIVIPVK
KNAEWWNMSPEERLKEMEVHTTPTLAYLVNVKRKLYHSTGLDDTDFITYF
ETDDLTAFNNLMLSLAQVKENKFHVRWGSPTTLGTIHSPEDVIKALADMQPMQSMKIERGTILTQPGVFGVFTMFKLRPDWNKVPVAERKGAAEEVKK
LIEKHKDNVLVDLYLTRGLETNSDFFFRINAYDLAKAQTFMREFRSTTVG
KNADVFETLVGVTKPLNYISKDKSPGLNAGLSSATYSGPAPRYVIVIPVK
KNAEWWNMSPEERLKEMEVHTTPTLAYLVNVKRKLYHSTGLDDTDFITYF
ETDDLTAFNNLMLSLAQVKENKFHVRWGSPTTLGTIHSPEDVIKALADFigure 4.3 DaCld chlorite dismutase sequence.
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